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Background and Aims 
Traditional Chinese medicine (TCM) has been increasingly popular among chronic 
hepatitis B patients but the understanding of its philosophies and methodologies is 
inadequate. The aims of current research were to evaluate the use of TCM among 
chronic hepatitis B patients, the practice of "Syndrome Differentiation for viral hepatitis" 
under TCM theory among TCM practitioners and the interpretation of TCM Syndrome 
Differentiation in the context of Western medicine theory and health-related quality of 
life. Two hospital clinic-based surveys for chronic hepatitis B patients and a 
population-based survey for TCM practitioners have been performed to investigate the 
TCM theories in the perspective of patients and TCM practitioners. A clinical study 
based on the syndrome diagnosis of three TCM practitioners has been performed to 
investigate the diagnostic and therapeutic agreements and the correlation of TCM 
diagnosis with laboratory results and health-related quality of life. 
Results and Conclusions 
* • In a hospital clinic-based survey of 362 chronic hepatitis B patients followed up in Prince 
� .. 
of Wales Hospital, 32% of patients have used TCM and over 75% of them had taken 
Chinese Medicine practitioners' prescription for the hepatitis. In another study among 
237 chronic hepatitis B patients, TCM symptomatology particularly those related to the 
gastrointestinal system had adverse impacts on patient's health-related quality of life. In 
a questionnaire survey of all registered TCM practitioners in Hong Kong, 529 (11%) of 
TCM practitioners have responded. Majority (96%) of the responding TCM 
practitioners were practicing Syndrome Differentiation for chronic hepatitis B based on 
TCM theory. With 3 TCM practitioners assessing patients independently in 112 chronic 
vi 
Precis 
hepatitis B patients, high average agreements on syndrome diagnosis (81%; Kappa-value 
0.72) and treatment principle (80%; Kappa-value 0.72) have been reached. The 
commonest consensual TCM syndromes including asymptomatic (33%), liver and kidney 
yin asthenia (32%), stagnation of liver qi and asthenia of spleen (24%), blood stasis in 
collateral (7.2%) were correlated with laboratory and quality of life data. The 
syndrome blood stasis in collateral was associated with worse coagulopathy and liver 
cirrhosis. The syndrome asymptomatic was characterized by better physical and mental 
aspects of health-related quality of life. 
In conclusion, TCM Syndrome Differentiation in chronic hepatitis B is widely practiced 
and has modest correlation to the severity of hepatitis in Western medicine theory as well 
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Chapter 1 Aims and Hypothesis 
Based on the understanding of the epidemiology of chronic Hepatitis B virus (HBV) 
infection in our locality and the popularity of Traditional Chinese Medicine (TCM) 
worldwide, TCM is believed to be one of the major choices of therapy for the treatment 
of chronic hepatitis B. A hospital based study on patients with chronic hepatitis B 
(diagnosed by positive HBsAg for a minimum of 6 months) was performed between 
April and May 2004 to evaluate the proportion of patients with chronic hepatitis B who 
use TCM and factors associated with the use. 
On the other hand, the diagnostic approach of TCM, "Syndrome Diagnosis", is primarily 
based on symptoms and signs, different from that of western medicine which emphasizes 
on laboratories findings. Therefore, a population-based survey on CMPs was performed 
from February to April, 2005 to assess the use of this diagnostic approach among local 
CMPs and its impact on their therapeutic approach. Another hospital based study 
among chronic hepatitis B patients was performed between April and May 2005 to 
evaluate the effect of TCM symptomatology and anxiety /depression and their 
relationships with HRQoL. 
fM 
Since "Syndrome Diagnosis" is primarily based on symptoms and signs, the clinical 
judgment might be subjective and the variety of diagnoses among different CMPs might 
be uncertain. Therefore, a clinical study was performed between November 2004 and 
March 2005 to evaluate the agreement of diagnostic and the corresponding therapeutic 
approach as well as the relationship of syndrome diagnosis and laboratory abnormalities. 
The aims and hypothesis of thesis can be summarized as follows. 
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1.1 Aims 
1. To study the proportion of chronic hepatitis B patients who use TCM, the types of 
TCM used, and the factors associated with the use of TCM. 
2. To investigate the practice behavior and professional knowledge of local CMPs as 
well as the factors affecting their practice behavior. 
3. To assess the HRQoL and factors affecting the HRQoL among chronic hepatitis B 
patients in Hong Kong. 
4. To investigate the agreement of syndrome diagnosis and treatment plan among 
CMPs and to evaluate the distribution of TCM diagnostic and therapeutic patterns 
in chronic hepatitis B patients. 
5. To study the relationship of TCM syndrome diagnoses in chronic hepatitis B with 
laboratory abnormalities and HRQoL. 
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1.2 Hypothesis 
1. A significant proportion of chronic hepatitis B patients use TCM. 
2. Syndrome Differentiation (Pattern Identification) is commonly practiced among 
Chinese Medicine Practitioners (CMPs) in Hong Kong. 
3. HRQoL of chronic hepatitis B patients is worse than the general population and the 
presence of TCM symptomatology is negatively related to HRQoL of chronic 
hepatitis B. 
4. The agreement of TCM diagnosis and treatment plan is good among different 
CMPs. 
5. Different TCM syndrome diagnoses correlate with different severity of liver 
disease. 
4 
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Chapter 2 Epidemiology of HBV Infection 
2.1 Global and Local Epidemiology 
Hepatitis B virus (HBV) infection is a public health problem of global importance. 
Approximately 350 million people worldwide are infected with HBV and become 
chronic carriers (Ganem and Schneider 2001; WHO 2002). In China, one tenth of the 
adult population are chronically infected with HBV (Gust 1996). The serious 
pathological consequences of persistent HBV infection include the development of liver 
cirrhosis and hepatocellular carcinoma (HCC). Chronic hepatitis B patients can be 
infectious, despite they are often asymptomatic. 
The prevalence of HBV infection varies in different geographic areas and can be divided 
into high, intermediate and low prevalence areas. High prevalence areas include 
Southeast Asia, sub-Saharan Africa, the Amazon Basin, and the central Asian Republics 
and some countries in Eastern Europe. In areas of high prevalence, approximately 70% 
to 90% of the population has been exposed to HBV infection before the age of 40, and 
8% to 20% of people are chronic HBV carriers. In Hong Kong and China, perinatal 
transmission is the major mode of spread accounting for 40%-50% of cases of chronic 
pi 
HBV infection. In intermediate prevalence areas including Mediterranean countries, 
Japan, India, and Singapore, the HBV carrier rate is approximately 3% to 5%. 
Horizontal spread during the first 2 years of life is the major mode of transmission. 
Low prevalence areas include North America, Western and Northern Europe, Australia, 
and parts of Southern America. The carrier rate for the hepatitis B surface antigen 
(HBsAg) is less than 2%, and less than 20% of the population has been exposed to HBV. 
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Table 2.1 Worldwide pattern of hepatitis B infection 
Endemicity Low Intermediate High 
HBsAg positive r a t e < 2 % 2-8% >8% 
Geographical North America Mediterranean South-east Asia 
Distribution Western Europe Central Asia China 
Northern Europe Japan Sub-Saharan Africa 
Australia Latin America the Amazon Basin 
New Zealand South America Alaska (Eskimos) 
Parts of Southern 
America 
Predominant age of Adult Early childhood Perinatal and early 
infection childhood 
Predominant mode Sexual Percutaneous Mother-infant 
of transmission Percutaneous Sexual Percutaneous 
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2.2 Modes of Transmission 
2.1.1 Perinatal Transmission 
The rate of transmission of HBV infection from mothers to neonates is less than 20% in 
Western countries. In endemic areas, China for example, maternal-infant transmission 
is the most common mode of transmission, accounting for a risk of 85%-90% for infants 
born to hepatitis B e-antigen (HBeAg) -positive mothers and 32% for infants born to 
HBeAg-negative mothers (Stevens et al., 1985). Passive-active immunization at birth 
has been demonstrated to be effective in preventing HBV infection in more than 90% of 
cases (Burke et al., 1994). 
2.1.2 Percutaneous Transmission 
Percutaneous inoculation of blood or body fluid plays a chief role in the transmission of 
HBV infection. Common routes include the sharing of needles by intravenous drug 
users, the reuse of contaminated needles for tattooing, acupuncture and ear piercing 
(WHO 2002). 
2.1.3 Sexual Transmission 
In developed countries, sexual transmission is the most essential mode of spread of HBV. 
A high prevalence of chronic hepatitis B infection has been reported in homosexuals and 
heterosexuals with multiple sex partners (Alter et al., 1990). 
2.1.4 Healthcare Setting and Transplantation 
HBV is the most commonly transmitted blood-borne virus in the healthcare environment 
(Gerberding 1996). Transmission often occurs from patients to patients or from patients 
to healthcare personnel via accidental needle sticks or contaminated instruments. 
Transmission of HBV infection has been reported after the transplantation of organs other 
8 
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than the liver and avascular tissues from HBsAg-positive donors (Hofl et al., 1997). 
2.1.5 Transfusion 
In the 1960s, the risk for acquiring hepatitis B infection from transfused commercial 
blood was as high as 50%. The exclusion of paid donors and the introduction of 
hepatitis B serologic screening in the 1970s drastically reduced the incidence of 
post-transfusion hepatitis B infection (Alter et al., 1972). 
2.1.6 Other 
In endemic areas, horizontal transmission among children may result from closely 
contacting minor skin breaks and mucous membranes. Transmission via contaminated 
environmental surfaces and daily use articles, such as toothbrushes, razors and earrings 
are also possible (Schiff et a!., 2002). 
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3.1 Traditional Chinese Medicine Use 
Traditional Chinese Medicine (TCM), the quintessence of the Chinese culture heritage, 
was considered as a form of complementary and alternative medicine in the West. It has 
a long history of over five thousand years as that of the Chinese nation and has made an 
everlasting contribution to the Chinese. Unlike other forms of traditional medicine 
which have largely become obselete, TCM continues as a distinct branch of modern 
medical practice. More importantly, TCM has been increasingly popular in the world. 
A rising trend of increased use of herbal products and its expense is obvious. Two and a 
half percent of American adults used herbal medicine in the preceding twelve months in 
1990, and the figure rose to 12.1 percent in 1997 (Eisenberg et al., 1998). The annual 
spending on herbal products by the general population has been estimated to exceed £ 
40 million per year in the United Kingdom and 5 billion US dollars per year in the 
United States (Eisenberg et al\ Vickers and Zollman 1999). According to the Customs 
Administration People's Republic of China in 2002，the import expense on TCM in Japan, 
Korea, Germany and the United States were 142 million, 48 million, 20 million and 20 
«M 
million US dollars, respectively (Jia 2005). The popularity of TCM has been increasing 
worldwide and a significant proportion of chronic hepatitis B patients in Hong Kong is 
receiving TCM (Wong et al., 2005). 
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3.2 Regulation on TCM Practice 
In Hong Kong, approximately 22% of the medical consultations are currently provided 
by Chinese medicine practitioners (CMPs). In 1999, Chinese Medicine Council of 
Hong Kong (CMCHK), a statutory body comprising Chinese medicine professionals, 
traders, academics, government officials and lay persons, was established. One of the 
goals of CMCHK was to setup of a registration system for CMPs and to implement the 
regulatory measures for Chinese medicine in order to ensure the professional standard 
and enhance the public confidence of CMPs (CMCHK 2006). The registration system 
for CMPs operates through a combination of examination, registration and discipline. A 
CMPs Board has been set up under the CMCHK to be responsible for implementing this 
registration system. 
Under Chinese Medicine Ordinance, all CMPs must be registered before they can 
practice Chinese medicine in Hong Kong (Chinese Medicine Ordinance 2000). 
Registered CMPs either have been thoroughly examined by the CMCHK or have been 
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4.1 Basic Principles 
TCM has its history as long as Chinese culture, and when its theories had been founded 
and systematized through Neijing thousands of years ago, including Yin-Yang Theory, 
the Five Elements Theory & Zang Fu Theory. 
4.1.1 Yin-Yang Theory 
The concept of Yin-Yang represents opposite but complementary qualities. The earliest 
origin of Yin-Yang phenomena was believed to derive from the peasants' observation of 
the cyclical alternation of day and night. Thus day corresponds to Yang and night to Yin, 
and by extension, activity to Yang and rest to Yin. Ancient Chinese applied yin-yang to 
the whole philosophy of TCM, and as a result, its pathology, diagnosis and treatment, can 
all reduced to the basic and fundamental theory of Yin and Yang (Maciocia 1989). 
4.1.2 Five Elements Theory 
The Five Elements are Water, Fire, Wood, Metal and Earth. Water moistens and 
^ downwards, Fire flares and upwards, Wood can be bent and straightened, Metal can be 
molded and can harden, Earth permits sowing, growing and reaping. This statement 
shows the 5 Elements symbolize five different inherent qualities and states of natural 
phenomena. These qualities and natural states forms the basic application of the 5 
Elements in TCM in areas like physiology, pathology, diagnosis, treatment, dietary and 
herbal therapy (Maciocia 1989). 
4.1.3 Zang Fu Theory 
The theory of Zang Fu (or Internal Organs) is often described as the core of TCM theory. 
At core, this theory represents a landscape of functional relationships which provide total 
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integration of bodily functions, emotions, mental activities, tissues, sense organs and 
environmental influences. The Internal Organs are functionally related to various vital 
substances, emotions, tissues and senses. Take the Liver System as an example, The 
Liver stores Blood (vital substance); controls the sinews and manifests in the nails 
(tissues); controls the eyes and sight (senses); relates to anger (emotion) (Maciocia 1989). 
Vi ,. 
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4.2 Pathogenesis 
Pathogenesis refers to the cause of disease. Identifying the cause of the patient's 
disharmony is an important part of Chinese medical practice. The primary exogenous 
factor of chronic hepatitis B in TCM is “Damp-heat,’; while the primary endogenous 
factor is deficiency of “Antipathogenic-qi” (or Vital Energy). The interaction of 
retention of ‘‘Damp-heat” and weakness of “Antipathogenic-qi” causes hepatitis B. 
Liver, is usually the first Zhang-organ which suffers; then Spleen, resulting in 
incoordination between the liver and the spleen, or stagnant of liver qi with spleen 
deficiency. More advanced patients may suffer from “blood stasis” and result in 
“Zheng-Jia” (or cirrhosis) (Mui 2003). Ancient Chinese classified hepatitis B as ‘‘yi-qi” 
which means infectious disease (Mui 2003). 
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4.3 Diagnosis 
TCM is intimately related to Syndrome Differentiation (or Pattern Identification), which 
is based on ancient philosophies, symptom-based clinical practice and a complicated 
individualized diagnostic system. The diagnosis of TCM syndromes emphasizes 
strongly on the fundamental principle that signs and symptoms reflect the condition of 
the Internal Organs {Zhang fu) or the body state. In Western medicine, however, 
chronic hepatitis B is usually regarded as a relatively asymptomatic disease. 
Non-specific symptoms have been described but their significance is rarely a major 
concern (Sherlock and Dooley 2002). Signs and symptoms in TCM (collaborately 
termed TCM symptomatology) are used to assess bodily functions such as taste, thirst, 
defecation, sleep pattern in order to create an overall picture of the disharmony inside 
patients. 
Patients who suffer from chronic hepatitis B may be classified into different syndromes 
according to their clinical manifestations (Kaptchuk 2000; Wang 2002). Based on the 
TCM theory, symptomatology of hepatitis is important in the diagnosis of different TCM 
patterns (or TCM syndromes) which guide the treatment strategy (Wang 2002a). "The 
«standards of TCM differential syndromes of viral hepatitis" was adopted by the 
investigators for Syndrome Differentiation (IMHC 1991). The TCM Syndromes are: 
1. Syndrome of damp-heat stasis in the middle-jiao (、濕熱中阻) 
A dysfunction of middle-jiao due to the accumulation of damp-heat., manifests as icterus, 
anorexia, nausea, fatty food phobia, hypochondriac and epigastric distention, dark yellow 
urine and yellowish and greasy tongue coating (IMHC 1991; Wang 2002a; Wang 2002b). 
17 
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This syndrome is further classified as Dampness outweighs heat and Heat outweighs 
dampness. 
2. Syndrome of stagnation of liver qi and asthenia of spleen (肝鬱脾虛) 
A morbid condition of hypofunction of the spleen and stomach causes by the stagnation 
of liver-energy; manifests as hypochondriac distending pain, abdominal distension, loose 
stool, emotional depression, irritability and susceptibility to rage, lassitude, light-whitish 
tongue with tooth-marked (IMHC 1991; Wang 2002a; Wang 2002b). 
3. Syndrome of liver and kidney yin asthenia (肝賢陰虛) 
An interior disturbance of asthenia-heat due to consumption of liver and kidney yin fluid 
and failure of yin to control yang, manifests as dizziness, eye dryness, aching and 
soreness of the loins and knees, hot sensation over the five centers (palms, soles and 
chest), insomnia and dreaminess, dull pain in the hypochondria which is aggregated by 
exertion, reddish dry tongue and thin and rapid pulse (IMHC 1991; Wang 2002a; Wang 
2002b). 
4. Syndrome of blood stasis in collaterals (瘀血阻絡） 
A morbid condition manifests as dullness complexion, hepatomegaly or splenomegaly 
with stiffness in nature, palmer erythema, spider naevi, needle-pricked sensation in 
hypochondria, peri-menstrual lower abdominal pain and dark menses with clot in women, 
cyanotic tongue and /or petechiae (IMHC 1991; Wang 2002a; Wang 2002b). 
5. Syndrome of pathogen concealing in the collaterals or Asymptomatic syndrome (牙 
伏脈絡） 
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Patients with two symptoms or less are classified into this syndrome (Cui and Xu 2002). 
This syndrome was not included in "The standards of TCM differential syndromes of 
viral hepatitis" but many chronic hepatitis B patients who have no symptoms according 
to the TCM theory would fit into this category (Fan et al., 2002). 
6. Syndrome of Spleen and Kidney yang asthenia (脾賢陽虛) 
A morbid condition of deficiency of yang both in spleen and kidney which manifests as 
cold intolerance, limbs coldness, infraumbilical region, waist and knee pain and coldness, 
loose stool, defecation at early morning, ankle edema and weak pulse (IMHC 1991; 
Wang 2002a; Wang 2002b). 
w. 
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4.4 Treatment 
The treatment strategy must conform to its own theory and laws in order to formulate a 
rational and coherent plan. The chief aim of TCM therapeutic approach is to restore the 
harmony of the body. Based on the above TCM diagnoses (Refer to 3.3), the 
corresponding treatment principles are: 
1. Syndrome of damp-heat stasis in the middle-jiao (、濕熱中阻) 
Damp-heat stasis in the middle jiao upsets the function of Spleen. As the spleen 
function of transformation and transportation of body fluids (a form of fluid that 
circulates nutrients around the body according to TCM theory) fails, the fluids will then 
accumulate to form Dampness. In order to remove the pathogenic factor damp-heat, the 
treatment strategy clearing away heat and promoting diuresis (清熱禾�J濕）was used. 
Yinchenhao Tang (茵陳蒿湯）and Yinchen Wuling San (茵陳五苓散）are the examples 
of herbal prescription. 
2. Syndrome of stagnation of liver qi and asthenia of spleen (肝鬱脾虛) 
Liver and spleen have a very close relationship. Stagnant liver qi disrupts the spleen 
ability to transform and transport food and body fluids and the upward flow spleen qi. 
When spleen is deficient and its transformation and transportation function impairs, this 
may affect the circulation of liver qi and impair the smooth flow of qi. Therefore, the 
treatment strategy Dispersing stagnant liver qi and strengthen spleen (疏肝健脾)is used 
to restore the harmony of the body. Xiaoyao San He Shen Ling Baizhu San (逍遙散 
合參茶白 7ft营女）is an example of herbal prescription. 
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3. Syndrome of liver and kidney yin asthenia (肝賢陰虛） 
The relationship between liver and kidney is based on the mutual exchange between 
blood and essence (blood and essence are the vital substances in TCM philosophy). 
Deficient of liver blood fails to nourish and replenish kidney yin and essence, and this in 
turn leads to the inability of the formation of blood (because the essence produces bone 
narrow which makes blood). In order to treat the deficiency, the treatment strategy: 
Nourishing liver blood and kidney yin (養肝益賢）is applied. Yiguan Jian he Liuwei 
Dihuang Wan (一貫煎合六味地黃九)is an example of herbal prescription. 
4. Syndrome of blood stasis in collaterals (瘀血阻絡) 
Blood circulates incessantly in the vessels and collaterals. When qi is stagnant, blood 
stasis in collaterals may result. In order to restore the circulation, the treatment strategy 
Activating blood and removing stasis (活血化瘀）is adopted. Gexia Zhuyu Tang (|鬲下 
逐瘀湯)is an example of herbal prescription. 
5. Syndrome of pathogen concealing in the collaterals or Asymptomatic syndrome (牙P 
伏脈絡） 
‘ T h e general condition of the body is relatively good. Pathogen conceals in the collateral 
and has not yet affected the Internal Organs. In order to improve the immune function 
and maintain normal physiological activities of the Internal Organs, the treatment 
strategy invigorating spleen and strengthening anti-pathogenic qi (健脾扶正）is applied. 
Shen Ling Baizhu San (參爷白 j)t散）is an example of herbal prescription. 
6. Syndrome of spleen and kidney yang asthenia (月卑賢陽虛) 
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The relationship between spleen and kidneys is one of mutual nourishment: the spleen is 
the root of post-heaven qi, while the kidneys are the root of pre-heaven qi. Pre-heaven 
qi and ^osi-heaven qi supports each other. When kidney yang is deficient, the fire of the 
gate of vitality (fire of the gate of vitality is a chief function of the kidney) cannot warm 
the spleen in its activity of transformation and transportation. In order to treat the 
deficiency, the treatment strategy Restoring spleen and kidney yang (、溫補脾賢)is 
adopted. Yougui Wan (右歸九)is an example of herbal prescription. 
v. 
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Chapter 5 Western Medicine 
5.1 Natural History of HBV Infection 
The natural course of HBV infection is mainly determined by the interaction between 
virus replication and host immune response. Other factors in the progression of 
HBV-related liver disease include HBV genotype and variants and host characteristics, 
including sex, age, racial /ethnic background, alcohol consumption, and concomitant 
infection with other hepatitis virus(es). 
5.1.1 Replicative Phase: Immune Tolerance 
In patients with perinatally acquired HBV infection (i.e. the first two or three decades of 
the life of a HBV carrier), the immune response is not active against but tolerates the 
virus, which can freely replicate in the liver. This phase is characterized by high levels 
of HBV replication (HBeAg positive and high levels of HBV DNA in serum yet no 
evidence of active liver disease), normal serum alanine aminotransferase (ALT) levels 
and minimal changes in liver biopsy (Chang et al., 1988; Chu et al., 1985; Lok and Lai 
1988). These patients are usually asymptomatic. 
5.1.2 Replicative Phase: Immune Clearance 
Spontaneous hepatitis B e-antigen (HBeAg) clearance occurs at an annual rate of 10 to 
20% between the age of 15 and 35 years in patients who perinatally acquired chronic 
HBV infection (Liaw et al., 1984; Lok et al., 1987). Serum ALT level is usually 
elevated, but the HBV DNA level falls and seroconversion of the HBeAg to hepatitis B 
e-antibody (anti-HBe) may occur. This immune response is probably caused by an 
immune-mediated lysis of infected hepatocytes. This stage causes minimal long-term 
damage to the liver if it is short and efficient. In some HBV carriers, however, the 
immune clearance is suboptimal and abortive (i.e. fail to clear the virus). Repeated 
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episodes of necroinflammation after a prolonged period of time may increase the risk of 
HBV-related fibrosis, cirrhosis and HCC. 
The initial phase of patients who acquire chronic HBV infection during adulthood is 
characterized by active viral replication (presence of HBeAg and HBV DNA in serum 
with active liver disease), elevated ALT levels, and chronic hepatitis on liver biopsy. 
5.1.3 Nonreplicating (Low-Replication) Phase 
This phase occurs as the third phase of perinatally acquired chronic HBV replication and 
the second phase of chronic HBV replication acquired in adulthood. Patients who 
undergo a successful immune clearance of the virus usually have negative HBeAg, 
positive anti-HBe, low or undetectable HBV DNA levels, normal ALT levels and a 
resolution of the necroinflammation on histology. However, some patients continue to 
have moderate levels of viral replication and active liver disease that may progress to 
cirrhosis after HBeAg seroconversion (Lok et al., 1984; Fattovich et al., 1986). These 
patients are regarded to have HBeAg-negative chronic hepatitis B. 
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5.2 Diagnostic tests for HBV infection 
5.2.1 Serologic Assays 
Hepatitis B surface antigen (HBsAg) is the serologic hallmark of hepatitis B infection. 
It appears in the blood approximately 6 weeks after infection and usually disappears 3 
months after the course of acute hepatitis B. Persistence for over 6 months implies the 
development of a chronic state (Sherlock and Dooley 2002). The disappearance of 
HBsAg is followed by the appearance of hepatitis B surface antibody (anti-HBs). The 
appearance of anti-HBs marks the recovery from and immunity of hepatitis B. 
Hepatitis B core antigen (HBcAg) is an intracellular antigen which is expressed in 
infected hepatocytes and is undetectable in serum. Its antibody, hepatitis B core 
antibody (anti-HBc), however, can be detected throughout the course of HBV infection. 
During acute HBV infection, anti-HBc is predominately immunoglobulin M (IgM) class 
which is the sole marker of HBV infection during the window period (i.e. the time 
interval between the HBsAg disappearance and anti-HBs appearance) (Perrillo et al., 
1983). Hence, the detection of IgM anti-HBc is usually taken as an indication of acute 
HBV infection. 
Immunoglobulin G (IgG) anti-HBc persists along with anti-HBs in patients who recover 
from acute hepatitis B and in association with HBsAg in patients who progress to chronic 
hepatitis disease. 
5.2.2 Serum Enzymes 
Enzymes, including alanine transaminase (ALT) and aspartate transaminase (AST) are 
released from the necrotic tissue to the blood since their production is increased during 
viral hepatitis. In acute HBV, elevated transaminase levels are usually useful for 
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screening and precede the onset of jaundice. In chronic HBV infection, disease activity 
prediction by transaminase is less reliable. Biochemical exacerbations with more than 
two to three fold elevation of transaminase levels usually occur during immune clearance 
of the virus (Liaw et al., 1983; Lok et al., 1987; Bortolotti et al., 1990). 
5.2.3 HBV DNA Assays 
The major role of serum HBV DNA assays in chronic HBV patients is to assess HBV 
replication and candidacy for antiviral therapy and to monitor the response to antiviral 
treatment (Perrillo et al., 1990). Rarely, tests for serum HBV DNA help to identify 
HBV as the etiology of liver disease in HBsAg-negative patients (Brechot et al, 1985; 
Paterlini et al., 1990). This test is especially essential in patients with fulminant 
hepatitis B, who may have cleared HBsAg by the time they present (Wright, et al., 1992). 
Nowadays, sensitive HBV DNA assays based on real-time PCR technology are available 
to detect HBV DNA to level below 100 copies /ml. 
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Table 5.1 Interpretation of HBV serological markers 
HBsAg HBV infection: acute or chronic 
HBeAg Replicative phase: high levels of HBV 
replication & infectivity 
Anti-HBe Low replicative phase: low levels of HBV 
replication & infectivity 
Anti-HBc IgM ii. Acute HBV infection (only serological 
marker present in the serological 
window) 
iii. Exacerbation of chronic HBV infection 
Anti-HBc IgG [ R e c o v e r e d HBV infection 
ii. Chronic HBV infection 
Anti-HBs Immunity of HBV infection 
i. Recovered HBV infection 
ii. Vaccinated 
Anti-HBc IgG + anti-HBs Past HBV infection “ 
Anti-HBc IgG + HBsAg Chronic HBV infection “ 
U 
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6.1 Principle and Definition 
Health-related quality of life (HRQoL) Refer to physical, psychological, and social 
domains of health that are influenced by people's experiences, beliefs, expectations, and 
perceptions on top of their prior and current health state. HRQoL is increasingly 
recognized as an important outcome measure in clinical and epidemiological studies of 
chronic illnesses and cancers (Wilson and Cleary 1995; Testa and Simonson 1996; 
Bayliss 1999; Brown 1999; Borgaonkar and Irvine 2000). 
Assessment of disease severity in chronic hepatitis B has focused on liver biochemistry, 
virology and liver-related complications. The relationship of HRQoL and chronic liver 
diseases has been studied in Western countries. Patients suffering from chronic liver 
diseases have substantially reduced HRQoL, which is mainly determined by psychiatric 
and medical comorbidities, older age and disease severity (Younossi et al.’ 2001; Hauser 
et al., 2004). Chronic hepatitis C, for example, is associated with a significant reduction 
of HRQoL (Bayliss et al., 1998; Foster et al., 1998; Neary et al., 1999; Ware et al., 1999). 
Studies on HRQoL of chronic hepatitis B patients are limited because of the relatively 
low prevalence of hepatitis B virus infection in the West. 
� ... 
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6.2 Assessment 
HRQoL assessment can be classified as generic and disease-specific measures of health 
outcomes. 
6.2.1 Generic Instrument 
Generic measures have the advantage of being comprehensive and reflecting public 
values. They provide a common denominator for comparing HRQoL across different 
groups, either healthy or diseased, and nations (Bayliss 1999). 
Medical Outcome Study 36-item Short Form Health Survey (SF-36) is a well-established 
and widely-used generic measurement with various language versions and cultural 
adaptation. This instrument was translated to and validated as Canton-Chinese Version 
(Hong Kong) (Lam et al” 1998). The Chinese (Hong Kong) version of SF-36 
questionnaire with good scaling assumptions and construct validity has been used to 
measure the HRQoL in Hong Kong. SF-36 consists of 36 items divided into 8 scales 
covering both physical health (physical functioning, role-physical or limitation in daily 
role functioning due to physical problems, bodily pain and general health) and mental 
health (vitality, social functioning, role-emotional or limitation in daily role functioning 
» ... 
due to emotional problems and mental health) (Ware and Kosinski 2000; Ware et al, 
2000). Norm-based scoring on 8 domains is adopted, with a scale of 0-100 on each 
domain. The raw scores of the 8 domains undergo z-score transformation and then 
norm-based transformation. These 8 scales can be aggregated into 2 component 
summary scores，namely physical summary component (PCS) and mental component 
summary (MCS). PCS and MCS are computed by summation of the local population 
standardized domain scores using a linear T-score transformation with a mean of 50 and a 
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standard deviation of 10. PCS and MCS are applicable in the local population as there 
is a high level of measurement equivalence of the scales with the population in the 
United States (Ware and Kosinski 2001; Lam et al., 2005). The reduction of the number 
of dimensions from 8 scales to 2 scores reduces the bias of chance in testing hypotheses 
related to health outcomes (Ware et al., 1995). 
6.2.2 Disease-Specific Instrument 
Disease-specific measures are useful in targeting issues which are relevant to patients 
with a particular condition, or disease, and tend to be more useful in determining whether 
specific effects have been achieved (Bayliss 1999). 
Validated disease-specific instruments, including the Liver Disease Quality of Life 
instrument (LDQOL 1.0) and Chronic Liver Disease Questionnaire (CLDQ) were 
developed in the West where very few chronic hepatitis B patients were involved 
(Bayliss et al, 1998; Younossi et al., 1999; Gralnek et al., 2000). To date, no validated 
Chinese version of disease-specific instrument is available for chronic hepatitis B. 
Efforts in translation and validation of these questionnaires in the Chinese population 
will be necessary to adjust for the cultural difference. 
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Chapter 7 Research Methodology 
7.1 Study 1: Hospital-based Surveys on Chronic Hepatitis B Patients: 
TCM Use 
7.1.1 Patients 
All out-patients with chronic hepatitis B (presence of positive HBeAg for over six 
months) attending the liver disease clinics at the Prince of Wales Hospital, Hong Kong 
during the 4-week period between April 12 and May 9, 2004 were recruited. 
Approximately 40% of our patients were referred from community-based screening 
program of asymptomatic subjects while the remaining 60% of patients were referred 
from family doctors for elevation of liver enzymes or symptomatic hepatitis (Chan et al., 
2000). We invited all Chinese patients aged 18 or above with chronic HBV infection 
regardless of the hepatitis B e-antigen status, activity of hepatitis or status of liver 
cirrhosis for this questionnaire survey. Patients with acute hepatitis B or co-infection 
with hepatitis C virus were excluded. 
7.1.2 Survey Instrument & Logistic 
A standardized questionnaire was developed to investigate the pattern of TCM usage 
among chronic hepatitis B patients. TCM was defined as any formula containing herbal 
medication ingredients either prescribed by CMPs or brought over the counter. The 
clarity of the questions was tested in a pilot study of twelve chronic hepatitis B patients. 
The questionnaire was divided into three parts. Briefly, part 1 of the questionnaire 
contained demographic and disease history questions including age, gender, occupation, 
marital status, duration of chronic hepatitis B since diagnosis, perception or knowledge 
of severity of liver disease, family history of liver disease and treatment (including TCM) 
for the liver disease if there was any. Part 2 of the questionnaire concentrated on the 
reasons why the patients did or did not use TCM. The perceived efficacy, adverse 
effects and expenditure were also asked among those patients who had used TCM. Part 
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3 of the questionnaire recorded the specific type and the source (over-the-counter or 
prescribed by CMPs) of herbal medicine used by the patients (Appendix I, P. 139). 
All patients who fulfilled the inclusion criteria were invited to complete the standardized, 
anonymous Chinese questionnaire with written informed consent. The questionnaires 
were completed in the waiting area before physician consultation. All patients filled out 
Part 1 and Part 2 of the questionnaire alone, and assistance was available to any patients 
with reading difficulties or on patients' request. The investigators would then proceed 
to directly question those patients who had used TCM to complete Part 3 of the 
questionnaire. All the questionnaires were returned on the same day of clinic visit for 
data entry and analysis (Wong et al., 2005). 
7.1.4 Statistical Analysis 
Data entry was performed by 2 independent investigators to ensure accuracy. Data 
derived from descriptive statistical analysis was presented in percentages for categorical 
data and mean 土 standard deviation for continuous data (applicable to all studies in the 
thesis). Continuous variables were compared by Student's t-test and categorical 
variables were compared by Pearson Chi's square test. To determine the independent 
factors associated with TCM usage, variables with ；？-value below 0.1 on univariate 
analysis were tested by multivariate logistic regression model. All statistical tests were 
two-sided. Statistical significance was taken as p < 0.05. All statistical analyses in 
this thesis were performed by Statistical Package of Social Science (SPSS version 11.5, 
Chicago, IL, USA). 
7.1.4 Sample Size Justification 
In the pilot study, five out of twelve patients had taken TCM. In this survey, the 
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response distribution of TCM usage was estimated to be 40%. The surveyed hospital 
clinic covered approximately one-sixth of the overall population in Hong Kong. As 
there were approximately 4000 chronic hepatitis B patients followed up in the liver 
disease clinics every year, the number of chronic hepatitis B patients followed up in all 
hospital-based clinics in Hong Kong per year was estimated to be 24,000. A survey 
including 362 patients would be required to determine a 40% response distribution of 
TCM usage at 95% confidence interval and 5% margin of error. 
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7.2 Study 2: Hospital-based Survey on Chronic Hepatitis B Patients: 
HRQoL & Psychiatric Involvement 
7.2.1 Patients 
Chinese chronic hepatitis B patients, aged 18 to 65, attending the liver clinics of Prince of 
Wales Hospital, Hong Kong between April and May 2005 were recruited in this study. 
Chronic hepatitis B was defined as documented positive serum HBsAg for a minimum of 
6 months (Refer to 4.2.1). Patients who had co-existence of other liver diseases or were 
unable to read Chinese were excluded. This study was approved by the clinical research 
ethics committee of the Chinese University of Hong Kong. 
7.2.2 Survey Instrument and Logistic 
All patients who fulfilled the inclusion criteria were invited to complete a standardized, 
anonymous Chinese questionnaire with written informed consent. The questionnaires 
were completed in the waiting area before physician consultation. Assistance was 
available to any patients with reading difficulties or on patients' request. The 
questionnaire consisted of 4 sections (Appendix II，P. 145): 
1. Socio-demographic characteristics and disease-related variables 
Questions on socio-demographic data included gender, age, marital status, education 
level, religious belief and family income. Questions on disease-related information 
included the duration of chronic hepatitis B since diagnosis, liver-related complications, 
comorbidities, treatments, and family history of chronic hepatitis B and its complications. 
2. Symptoms severity assessment 
Based on the result of a pilot study, 14 TCM-based symptoms were identified in at least 
20% of chronic hepatitis B patients. These symptoms included discomfort over lateral 
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part of chest wall, pruritus, dry eyes, dizziness or headache, soreness of back and/or knee, 
bodily hotness (at hands, foot or chest), insomnia, nausea, abnormal sensation in taste, 
thirst, anorexia, dyspepsia, post-prandial abdominal distension or belching and change in 
bowel habit (Wang 2002b). The severity of these symptoms was assessed by a 7-point 
Likert scale from 1 (minimal) to 7 (most severe). 
3. Hospital Anxiety and Depression Scale (HADS) 
This scale was designed and validated for the assessment of anxiety and depression in 
patients with physical illness in the setting of a hospital medical outpatient clinic and 
general medical ward (Zigmond and Snaith 1983; Leung et al., 1999). This 
Chinese-Cantonese version of the HADS demonstrated good agreement with the English 
original, with comparable linguistic, structural and scale equivalence (Leung, Ho et al. 
1993). Both the anxiety scale (HADS-A) and depression scale (HADS-D) have 7 items 
rated on a 4-point Likert scale from 0 (not present) to 3 (always present). The anxiety 
and depression scores were calculated by summation of the responses of corresponding 
items. Responders with scores 11 or above on either subscale indicated the possibility 
of depression or anxiety disorder. 
v 4. Medical Outcome Study 36-item Short Form Health Survey (SF-36) 
The Chinese (Hong Kong) version of SF-36 questionnaire was used to measure the 
HRQoL (Refer to 5.2.1). The summary scores, PCS and MCS, were computed to assess 
patients' HRQoL (Lam et al., 1999; Ware and Kosinski 2000). 
7.2.3 Statistical Analysis 
Data entry was performed by 2 independent investigators to ensure accuracy. The TCM 
symptom-severity assessment, a 7-point Likert scale, was transformed to a 5-point Likert 
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scale by recoding rank 6 and 7 to rank 5 due to the rare reports of extreme symptom 
severity (Table 9.2). 
To determine the factors associated with HRQoL, demographic variables, disease-related 
variables, symptoms scores and HADS scores were correlated with the PCS and MCS by 
linear regression model. Variables that were associated with PCS and MCS on 
univariate analysis (P < 0.1) were further analyzed by stepwise regression model for 
independent predictors of HRQoL. Two-way interaction terms together with all 
variables that were associated with PCS and MCS were further analyzed by stepwise 
regression model to assess the interaction effects to the main effects model. These 
interaction terms were based on the independent predictors of PCS and MCS on 
multivariate analysis, and the interactions among demographic variables, TCM 
symptoms and HADS were analyzed. All statistical tests were two-sided and statistical 
significance was taken as 尸 < 0.05. 
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7.3 Study 3: Population-based Survey on Chinese Medicine 
Practitioners: Practice Behavior & Knowledge Assessment 
7.3.1 Study Population 
All registered CMPs (n = 5011) with addresses available from the website of Chinese 
Medicine Council of Hong Kong on January 20, 2005 were included in our study 
(CMCHK 2005). Due to the Personal Data (Privacy) Ordinance in Hong Kong, one 
hundred and seventy-three CMPs did not release their complete mailing address in the 
database. A self-administered, anonymous questionnaire, an invitation letter and a 
self-addressed stamped envelope was mailed to each of the eligible CMP in March, 2005. 
The completed questionnaire was requested to return within one month. Three retirees 
who were no longer involved in clinical practice were excluded. A total of 4835 CMPs 
were eligible in the study. The study protocol was approved by the local ethics 
committee. 
7.3.2 Survey Instrument 
The questionnaire included four sections covering diagnostic and therapeutic approaches, 
professional knowledge and demographic information of the CMPs. The questionnaire 
was pilot-tested among 25 local TCM university students who were in their clinical years 
to ensure the clarity of the questions before use. Section 1 of the questionnaire focused 
on the CMP s' diagnostic approach and practice behavior to chronic hepatitis B. The 
consideration of western medicine diagnosis and use of TCM Syndrome Differentiation 
were inquired in this section. Section 2 of the questionnaire was divided into 2 parts. 
CMPs who practiced TCM Syndrome Differentiation were inquired on their opinions on 
the therapeutic approach to each TCM syndrome and their knowledge on TCM 
syndrome-specific symptoms (Refer to 7.3.3). Those CMPs who did not practice 
Syndrome Differentiation were inquired on their alternative therapeutic approach to 
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chronic hepatitis B. Section 3 of the questionnaire inquired the specific treatment 
modality of CMPs to chronic hepatitis B. Section 4 of the questionnaire inquired the 
education background and other demographic details of the CMPs. (Appendix III, P. 161) 
7.3.3 Statistical Analysis & Knowledge Assessment 
Goodness-of fit test was used to compare the distribution of the locations of the CMPs 
who responded to the survey against the overall geographical distribution of CMPs in 
Hong Kong. In order to confirm the comparability of the sample and population, we 
requested the demography, education and professional background of the target 
population from local government authorities including Department of Health, Census 
and Statistical Department, and Chinese Medicine Council of Hong Kong. However, 
the above information was not available from these organizations. 
A list of constituent symptoms of each TCM syndrome according to textbooks and "The 
standards of TCM differential syndromes of viral hepatitis" (IMHC 1991; Wang 2002a; 
Wang 2002b) was used to assess the professional knowledge of the CMPs of TCM 
syndrome differentiation. The assessment was also based on "The standards of TCM 
differential syndromes of viral hepatitis" (Refer to 3.3). TCM symptoms and signs can 
be further classified into primary and secondary symptoms according to the significance 
.. 
of the syndromes (IMHC 1991). The CMPs had to select the symptoms they regarded 
as relevant to the respective TCM syndrome. In order to assess CMPs' knowledge on 
TCM diagnosis, the following formulae were applied: 
Syndrome Score = S [(2 x selected primary symptoms) + (1 x selected secondary 
symptoms)] x 100% / S [(2 x total number of primary symptoms) + (1 x total number of 
secondary symptoms)] 
Average Syndrome Score =1 Syndrome Score x 100% / S Total number of syndromes 
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Chi-square test or Fisher exact test were used to assess the relationship of demographic 
variables and practice behavior with the use of TCM differential diagnosis whenever 
appropriate. Demographic variables that might associated with professional knowledge 
scores on univariate analysis (P < 0.1) were further analyzed by stepwise regression 
model for independent predictors of professional knowledge. All statistical tests were 
two-sided and statistical significance was taken as P < 0.05. 
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7.4 Study 4: TCM Consultation Agreement 
7.4.1 Patients 
Consecutive patients with chronic HBV infection seen by a single hepatologist were 
recruited from the Hepatitis Clinic of the Prince of Wales Hospital, Hong Kong between 
November 2004 and March 2005. Chronic hepatitis B was diagnosed by positive 
HBsAg for a minimum of 6 months (Refer to 4.2.1). Exclusion criteria were active 
interferon and/or anti-viral treatment, co-infection with hepatitis C virus, decompensated 
liver disease and its related complications including ascites, bleeding varices, 
spontaneous bacterial peritonitis and hepatic encephalopathy, serious medical or 
psychiatric illnesses, and condition that would interfere TCM Syndrome Differentiation 
including previous gastrectomy and cholecystectomy. All patients gave written 
informed consent for participation in this study. The study protocol was approved by 
the university clinical research ethics committee. 
7.4.2 Chinese Medicine Practitioners 
Three licensed CMPs graduated from different TCM universities in Hong Kong and 
mainland China participated in this study. The clinical experiences ranged from fresh 
university graduate to over twenty years of clinical practice. 
7.4.3 Questionnaire 
A standardized questionnaire was developed and pilot-tested in 20 patients. The first 
part of the questionnaire was self-administered by patients on the symptomatology of 
TCM syndromes. The second part of the questionnaire included the clinical signs of the 
TCM syndromes and was completed by the 3 CMPs after patient assessment (Appendix 
IV, P. 168). 
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7.4.4 Study Design 
Chronic hepatitis B patients were screened by the hepatologist and eligible patients were 
invited to complete a standard questionnaire. This questionnaire focused on the 
symptomatology of the syndromes and served as a substitute for "Inquiry" in the "Four 
diagnostic Method" of TCM. All patients were then examined by the three CMPs 
independently on the pulse, tongue and physical signs. The clinical signs were recorded 
in the second part of the questionnaires by the CMPs without discussion. Based on the 
self-administered symptomatology as reference, each TCM practitioner provided a TCM 
Syndrome Differentiation diagnosis, principle of treatment and herbal formula 
prescription for each individual patient from a pre-set list. The diagnostic reference was 
based on "The standards of TCM differential syndromes of viral hepatitis" (Refer to 3.3). 
The syndrome Kidney and liver yang asthenia originally presented in the diagnostic 
standard was excluded from the list because this syndrome was extremely rare among 
chronic hepatitis B patients in our locality. 
7.4.5 Sample Size Estimation 
The primary outcome measure was the percentage of agreement among the 3 CMPs in 
making the TCM diagnoses. Based on a previous study on irritable bowel syndrome, 
the average percentage of agreement among different CMPs was approximately 80% 
(Sung et al., 2004). To determine this agreement percentage at 99% confidence interval 
with desired half width of confidence interval of 10%, 107 patients were required to be 
recruited in this study. 
7.4.6 Data Analysis 
Agreement rates among the 3 CMPs in diagnoses, management principles and treatment 
regimens were computed in simple percentages. Kappa-values between any two CMPs 
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were also presented and the mean kappa-values of individual items were derived by 
averaging the sum of simple kappa-values (Sung et al, 2004). A two-sided ；?-value of < 
0.05 was considered to be statistically significant. 
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7.5 Study 5: TCM Interpretation of Laboratory, Imaging & HRQoL 
Assessment 
7.5.1 Patients 
Study 5 was an extended work of Study 4. Patients with TCM diagnosis agreed by two 
or more of the CMPs were included in the analysis. All patients had laboratory 
investigations including complete blood count, clotting profile, liver and renal 
biochemistries, HBeAg and anti-HBe, HBV DNA and alfa-fetoprotein on the same day 
of interview. Ultrasound examination results within 2 yeas were retrieved from the case 
record. 
7.5.2 HRQoL Assessment 
Patients were invited to complete the Chinese (Hong Kong) version of SF-36 on the same 
day of examination in order to measure their HRQoL (Refer to 7.2.1). Scores of 8 
domains and 2 component summaries were used to assess HRQoL. 
7.5.3 Statistical Analysis 
The associations of consensual TCM syndromes with clinical variables and HRQoL 
measurement were tested by analysis of variances, Kruskal-Wallis test or 
Fisher-Freeman-Halton test as appropriate. Variables that were associated with TCM 
syndromes were further analyzed by Student's t-test, Mann Whitney U test, chi-square 
test or Fisher exact test as appropriate. All statistical tests were two-sided. 
Bonferroni's correction was used to adjust for multiple comparisons. Statistical 
significance was taken as P < 0.05 /number of comparisons. 
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8.1 Patient Characteristics 
In Study 1，three hundred and eighty-eight chronic hepatitis B patients attended the liver 
disease clinics over the four-week period (April 12 — May 9，2004). Fourteen patients 
did not return the questionnaires and eleven patients did not consent to the questionnaire 
survey. One returned questionnaire was invalid as that patient did not indicate the usage 
of TCM. In total, three hundred and sixty-two (93%) patients had properly completed 
questionnaires for analysis. Two hundred and ten (58%) patients had received high 
school education or above. Two hundred and fifty-seven (72%) patients were in 
employment while the others were housewives, students, unemployed or retired. One 
hundred and eighty-six (52%) patients had a monthly salary of 10,000 or higher. One 
hundred and ten (30%) patients had traveled to Mainland China in the past year for over 
a week (Table 8.1). 
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Table 8.1 Characteristics of patient in the survey 
Characteristics Result Evaluable patients (n, %) 
Age (year) 44 士 13 360 (99.4%) 
Male gender (n，％) 239 (66.0%) 362 (100%) 
Married (n,%) 277 (76.5%) 362 (100%) 
Education level ~ 361 (99.7%) 
Junior secondary or below 151 (41.8%) 
High school 107 (29.6%) 
Tertiary education or above 103 (28.5%) 
Working status 358 (98.9%) 
Professionals 27 (7.5%) 
White collar group 139 (38.8%) 
Blue collar group 91 (25.4%) 
Non-working 101 (28.2%) 
Monthly income (HK$) 358 (98.9%) 
< 5000 / month 107 (29.9%) 
5000 - 10000 / month 65 (18.2%) 
10000 - 20000 / month 96 (26.8%) 
> 20000 / month 90 (25.1%) 
Travel to mainland China in the past year 361 (99.7%) 
Never 107 (29.6%) 
Less than 1 week 144 (39.9%) 
1 week to 1 month 60 (16.6%) 
Over 1 month 50(13.8%) 
—Duration of chronic hepatitis B (year) 11.6士8.2 361 (99.7%) — 
Perception of active disease 362 (100%) 
Yes 94 (26.0%) 
No or don't know 268 (74.0%) 
Knowledge of liver cirrhosis 362 (100%) 
Yes 86 (23.8%) 
No or don't know 276 (76.2%) 
Family member/friends with chronic 362(100%) 
hepatitis B 
‘ Yes 220 (60.8%) 
No 142 (39.2%) 
Family member/friends with HCC* 362 (100%) 
Yes 88 (24.3%) 
No 274 (75.7%) 
Previous use of Western medication 362 (100%) 
Yes 106 (29.3%) 
No 256 (70.7%) 
*HCC = hepatocellular carcinoma 
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8.2 Health-Seeking Behavior of TCM Users 
One hundred and sixteen (32%) patients reported using TCM, and 58 (50%) of them 
were actively using TCM at the time of the Study 1. Among them, 66 (57%) of patients 
received TCM from CMPs, 28 (24%) patients bought it over the counter, and 22 (19%) 
patients obtained the medicine from both sources. Seventy-six (67%) patients spent less 
than US$65 per month on TCM, 20 (18%) patients spent US$65 to US$130 while 18 
(16%) patients spent more than US$130 per month (2 patients had missing information). 
Forty-eight (42%) patients rated TCM as very effective or effective in the treatment of 
chronic hepatitis B，47 (42%) patients found the effectiveness fair while only 18 (16%) 
patients thought that TCM had little or no effect (3 patients had missing information). 
On the other hand, 105 (91%) patients felt that TCM had few or no side effects, 9 
patients found the side effects were moderate and only 1 patient experienced severe side 
effects (1 patients had missing information). Only 58 (50%) patients had informed their 
physicians regarding the use of TCM. Most (81%) patients who did not inform their 
physician on TCM usage did not think this information was important. 
Sixty (52%) patients obtained information on TCM from relatives or friends, while 35 
(30%) patients obtained the information from CMPs. Minority of patients obtained the 
information from various sources including the internet, advertisements, recommendation 
from other patients or their physicians. 
Forty-four (38%) out of 116 patients who preferred taking TCM were recommended by 
relatives or friends. Twenty-five (22%) patients took TCM because they thought it was 
better than Western medicine. Nineteen (16%) patients took TCM because they did not 
get any prescription from their physicians in the hospital clinic. Other reasons for 
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using TCM included personal preference, concern about the adverse effect of western 
medication and influence by the mass media. 
In contrast, among 246 patients who did not use TCM, 88 (36%) patients felt that they 
did not require any treatment and 66 (27%) patients did not believe in the efficacy of 
TCM or were worried about the safety of the medication. Other reasons for not using 
TCM included inconvenient preparation (25 patients, 10%), advice from physician or 
relatives (21 patients, 9%) and other miscellaneous reasons. One hundred and forty 
(57%) patients had heard of the potential benefit of TCM in treating chronic hepatitis B 
by the date of the study. 
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8.3 Determinants of TCM Use 
In addition to the demographic characteristics, factors that might reflect the perception of 
liver disease were also analyzed in relation to traditional Chinese medication usage. On 
univariate analysis, several factors were found associated with the use of TCM, namely 
male gender, higher monthly salary, recent travel to Mainland China, longer duration 
since the diagnosis of chronic hepatitis B, perceived active liver disease activity, 
knowledge of presence of liver cirrhosis, family members or friends with chronic 
hepatitis B and previous use of Western medicine (Table 8.2). Other factors including 
age, marital status, education, employment status and family history of hepatocellular 
carcinoma had no association with TCM usage. On multivariate analysis, recent travel 
to Mainland China, perceived active disease activity and family members or friends with 
chronic hepatitis B were independent factors associated with the use of TCM (Table 8.3). 
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Table 8.2 Comparison of chronic hepatitis B patients who used traditional Chinese 
medicine and those who did not. Continuous variables are presented as mean 士 
standard deviation. Categorical variables are presented as number (%)• 
Characteristics Patients using TCM Patients not using TCM /?-value 
(n= 116) (n = 246) 
Male gender 86 (74%) 153 (62%) 0.03 
Age 44 士 11 44 士 13 0.97 
Married 89 (77%) 188 (76%) 1.00 
High school education or 71 (62%) 139 (57%) 0.35 
above 
Working group 90 (78%) 167 (69%) 0.06 
Monthly salary above 68 (60%) 118 (48%) 0.05 
HK$ 10,000 
Travel to Mainland China 48 (42%) 62 (25%) 0.001 
over 1 week in the past 
year 
Duration of diagnosis of 14 士 9 11 ± 7 0.001 
chronic hepatitis B (years) 
Perceived active liver 46 (40%) 48 (20%) <0.001 
disease 
Knowledge of liver 36 (31%) 50 (20%) 0.03 
cirrhosis » 
4 Family members or 84 (72%) 136 (55%) 0.002 
friends with chronic 
hepatitis B 
Family members or 33 (28%) 55 (22%) 0.21 
friends with hepatocellular 
carcinoma 
History of treatment by 47 (41%) 59 (24%) 0.001 
Western medicine 
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Table 8.3 Multivariate analysis of factors associated with the use of traditional Chinese 
medicine among chronic hepatitis B patients 
Factors Adjusted odds ratio 95% confidence interval ^-value 
Perceived active liver 2^07 1.21-3.55 0.008 
disease 
Family members of friends 2.00 1.17-3.42 0.01 
with chronic hepatitis B 
Travel to Mainland China 1.88 1.13-3.16 0.02 
over 1 week in the past year 
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8.4 Common Herbal Ingredients Used 
Table 8.4 illustrates the identifiable herbal ingredients used by more than 10 percent of 
the responders in Study 1. Eight-three (72%) of patients could identify the major 
ingredient of the herbs. Fifty-five (47%) patients were on herbs with more than 1 
ingredient. The most frequently used herbal ingredients were Abrus cantoniensis, 
followed by Ganoderma lucidum and Atractylodes macrocephala. 
56 
Chapter 8 TCM Use on Chronic Hepatitis B Patients 
Table 8.4 Commonly used herbal ingredients by 116 chronic hepatitis B patients. The 
list includes herbal components used by more than 10% of the responders. 
Herbal components Chinese names Percentage 
Abrus cantoniensis Hance 雞骨草 53 
Ganoderma lucidum 靈芝 28 
Atractylodes macrocephala 白朮 28 
Poria cocos 茯苓(云苓） 24 
Schisandra chinensis 五味子 21 
Salvia miltiorrhiza 丹參 18 
Ligustrum lucidum 女貞子 13 
Cordyceps sinensis 冬蟲夏草 10 
Phyllanthus urinaria 葉下珠 3 
f* 
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9.1 Patient Socio-Demographic and Clinical Characteristics 
In Study 2, two hundred and thirty-seven patients with chronic hepatitis B were invited to 
participate in the study. Two hundred and twenty-six (95%) patients consented and 
completed the questionnaire (Table 9.1). Nine patients refused consent and two 
questionnaires went missing. Among the 226 patients studied, 163 (72.1%) patients 
were male and the mean age was 44 士 13. The majority of patients had received 
secondary education or above (81.3%). Approximately half of the studied patients had 
chronic hepatitis B diagnosed for more than 10 years. Sixty-seven (29.6%) patients had 
liver cirrhosis and 6 (2.7%) patients had history ofHCC. Sixty-six (29.2%) patients had 
one or more comorbid illnesses including diabetes mellitus (10.2%), hypertension (8.8%), 
renal disease (7.5%) and chronic lung disease (4.4%). Nearly half of the patients had 
positive family history of chronic hepatitis B, indicating the possibility of perinatal 
hepatitis B virus transmission. 
耻 .， 
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Table 9.1 Clinical and demographic characteristics of chronic hepatitis B patients 
recruited into the study (n=226) 
" N % 
M l k 163 ~ ~ 
Age (yr) 44 土 13 
Education level 
Primary or below 42 18.7 
Secondary 119 52.9 
Tertiary 64 28.4 
Presence of religious belief 61 26.7 
Monthly Family Income ($) 
<10000 53 23.8 
10000-20000 86 38.6 
20000-30000 39 17.5 
>30000 45 20.2 
Married 170 75.2 
Years since diagnosis 11 ± 9 
Complications of Cirrhosis/ HCC* 68 30.1 
Presence of comorbidities 66 29.2 
Anti-HBV treatment 84 37.2 
TCM practitioner prescription 39 17.3 
Health product consumption 96 42.7 
Family history of chronic hepatitis B 107 47.3 
Family history of cirrhosis/ HCC* 36 15.9 
All values are expressed in numbers and percentage (%), 
Age and years of diagnosis are expressed in mean 土 SD. 
*HCC = hepatocellular carcinoma 
60 
Chapter 9 Impacts of HBV Infection on Patients 
9.2 Patients' Symptoms and Anxiety /Depression 
The scores of symptoms were on the low side of the Likert scale with mean scores 
ranging from 1.9 to 3.9 indicating mild symptom severity (Table 9.2). The scores on 
HADS-A (5.8 士 3.9) and HADS-D (4.5 士 3.7) were low, indicating mild psychiatric 
involvement. Thirty-two (14.2%) patients had HADS-A ^ 1 1 and 20 (8.8%) patients 
had HADS-D ^ 11, indicating the possibility of depression or anxiety disorder. 
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Table 9.2 Symptom severity assessment, scores ofHADS and SF-36 of chronic 
hepatitis B patients 
Score 
Symptoms ~ ( 1 - 5 ) ' mean 土 SD. 
Discomfort over the lateral part of chest wall 2.4 士 1.3 
Pruritus 2.8 士 1.3 
Dry eyes 2.7 ±1.4 
Dizziness or headache 2.7 士 1.2 
Soreness of back and/or knee 3.0 士 1.3 
Bodily hotness (at hands, foot or chest) 1.9 士 1.2 
Insomnia 2.8 土 1.3 
Nausea 1.7 ±1.0 
Abnormal taste 2.7 士 1.3 
Thirst 2.9 ± 1.3 
Anorexia 2.6 士 1.3 
Dyspepsia 2.9 士 1.3 
Post-prandial abdominal distension or belching 2.2 士 1 • 1 
Change in bowel habit 2.4 ±1.2 
Hospital Anxiety and Depression Scale (0-21) 
Anxiety score (HADS-A) 5.8 士 3.9 
Depression score (HADS-D) 4.5 士 3.7 
SF-36 
Physical component summary (PCS) 45.37 土 10.41 
Mental component summary (MCS) 47.25 土 11.32 
* Symptoms severity assessment was based on a 7-point Likert scale transformed to a 
5-point Likert scale. 
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9.3 HRQoL & its Determinants 
9.3.1 Physical Aspect of HRQoL 
The mean PCS was 45.37 士 10.41 (Table 9.2). On univariate analysis, older age, lower 
family income, being married, lower education level, presence of liver cirrhosis or 
history of HCC, presence of comorbid illnesses, absence of family history of chronic 
hepatitis B，and higher TCM symptoms scores and higher depression scores on HADS 
(i.e. more severe symptoms and depression involvement) were associated with worse 
PCS (Table 9.3a & 9.3b). On multivariate analysis，comorbidities, presence of liver 
cirrhosis or history of HCC, presence of TCM symptoms including discomfort over the 
lateral part of chest wall and soreness of back and/or knee, and higher depression scores 
on HADS remained independently associated with worse PCS (Table 9.3c). When 
2-way interaction terms were included on multivariate analysis, presence of 
comorbidities-by-soreness of back and/or knee, and discomfort over the lateral part of 
chest wall-by-higher depression scores on HADS were significantly associated with 
worse PCS. 
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Table 9.3a Univariate analysis for demographic and clinical variables associated with 
PCS by linear regression model 
95%Confidence 
Interval for p 
Variables P Lower limit Upper limit /?-value 
Sex -1.014 -4.061 2.033 0.513 
Age -0.233 -0.334 -0.131 <0.001 
Family Income 1.406 0.128 2.685 0.031 
Married -4.355 -7.470 -1.240 0.006 
Education level 2.107 0.105 4.109 0.039 
Presence of religious belief 1.272 -1.804 4.348 0.416 
Years since diagnosis -0.110 -0.270 0.050 0.175 
Complications of cirrhosis/ HCC* -4.889 -7.800 -1.977 0.001 
Comorbidities -5.832 -8.740 -2.924 <0.001 
Family history of chronic hepatitis B 2.413 -0.308 5.133 0.082 
Family history of cirrhosis/ HCC* -1.509 -5.241 2.223 0.426 
, * H C C = hepatocellular carcinoma 
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Table 9.3b Univariate analysis on symptoms scores and HADS scores associated with 
PCS by linear regression model 
~ 95%Confidence 
Interval for p 
Variables P Lower limit Upper limit /?-value 
Symptoms Scores 
Discomfort over the lateral part of -3.875 -4.863 -2.887 <0.001 chest wall 
Pruritus -1.893 -2.940 -0.846 <0.001 
Dry eyes -1.163 -2.191 -0.134 0.027 
Dizziness or headache -2.716 -3.815 -1.617 <0.001 
Soreness of back and/or knee -3.565 -4.525 -2.604 <0.001 
Bodily hotness (at hands, foot or 
-2.162 -3.341 -0.983 <0.001 
chest) 
Insomnia -2.763 -3.769 -1.758 <0.001 
Nausea -2.527 -3.915 -1.138 <0.001 
Abnormal taste -2.870 -3.874 -1.865 <0.001 
Thirst -2.555 -3.561 -1.548 <0.001 
Anorexia -3.205 -4.190 -2.220 <0.001 
Dyspepsia -2.592 -3.626 -1.559 <0.001 
Post-prandial abdominal distension or 
-3.306 -4.478 -2.133 <0.001 belching 
Change in bowel habit -3.337 -4.374 -2.300 <0.001 
Hospital Anxiety and Depression 
. Scale 
Anxiety score (HADS-A) -1.009 -1.347 -0.670 <0.001 
Depression score (HADS-D) -1.529 -1.861 -1.196 <0.001 
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Table 9.3c Multivariate analysis for independent factors associated with PCS in main 
effects model 
PCS 95% C.I. for p 
P Lower Upper /?-value 
Factors 
Limit Limit 
Comorbidities - 4 . 1 4 9 - 6 . 5 9 4 - 1 . 7 0 5 0 . 0 0 1 
Complication to cirrhosis /HCC* -1.052 -5.066 -0.214 0.033 
Discomfort over the lateral part of chest wall -1.901 -2.724 -0.854 <0.001 
Soreness of back and/or knee -1.312 -2.791 -1.012 <0.001 
Depression score (HADS-D) -1.052 -1.382 -0.214 <0.001 
*HCC = hepatocellular carcinoma 
鳅. .， 
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9.3.2 Mental Aspect ofHRQoL 
The mean MCS was 47.25 士 11.32 (Table 9.2). On univariate analysis, younger age, 
presence of religious belief, family history of chronic hepatitis B and higher TCM 
symptoms scores, higher anxiety and depression scores on HADS were associated with 
worse MCS (Table 9.4a & 9.4b). On multivariate analysis, younger age, presence of the 
TCM symptoms including abnormal taste and post-prandial abdominal distention or 
belching, higher anxiety and depression scores on HADS remained independently 
associated with worse MCS (Table 9.4c). When 2-way interaction terms were included 
on multivariate analysis, younger age-by-higher anxiety scores on HADS and abnormal 
taste-by-post-prandial abdominal distention or belching were independently associated 
with worse MCS. 
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Table 9.4a Univariate analysis for demographic and clinical variables associated with 
MCS by linear regression model 
95% CI for P 
Lower Upper 
Variables P ^-value 
limit limit 
Sex 0.410 -2.905 3.725 0.808 
Age 0.137 0.024 0.251 0.018 
Family Income 0.376 -1.053 1.804 0.605 
Married -0.630 -4.072 2.812 0.719 
Education level -0.946 -3.139 1.248 0.396 
Presence of religious belief -3.048 -6.372 0.277 0.072 
Years since diagnosis 0.053 -0.124 0.229 0.557 
Complications of cirrhosis/ HCC* 2.307 -0.919 5.534 0.160 
Comorbidities 2.355 -0.900 5.610 0.155 
Family history of chronic hepatitis B -3.489 -6.431 -0.547 0.020 
Family history of cirrhosis/ HCC* -3.044 -7.087 0.998 0.139 
*HCC = hepatocellular carcinoma 
68 
Chapter 9 Impacts of HBV Infection on Patients 
Table 9.4b Univariate analysis on symptoms scores and HADS scores associated with 
MCS by linear regression model 
_ 95%Confidence 
Interval for p 
Variables P Lower limit Upper limit p-value 
Symptoms Scores 
Discomfort over the lateral part of -3.831 -5.110 -2.552 <0.001 
chest wall 
Pruritus -1.759 -3.068 -0.450 0.009 
Dry eyes -2.779 -4.009 -1.548 <0.001 
Dizziness or headache -3.840 -5.162 -2.518 <0.001 
Soreness of back and/or knee -3.032 -4.290 -1.773 <0.001 
Bodily hotness (at hands, foot or 
-3.696 -5.112 -2.280 <0.001 
chest) 
Insomnia -3.544 -4.779 -2.310 <0.001 
Nausea -3.883 -5.569 -2.196 <0.001 
Abnormal taste -4.019 -5.233 -2.805 <0.001 
Thirst -4.403 -5.576 -3.230 <0.001 
Anorexia -3.593 -4.828 -2.358 <0.001 
Dyspepsia -2.921 -4.209 -1.634 <0.001 
Post-prandial abdominal distension 
-5.128 -6.517 -3.740 <0.001 
or belching 
Change in bowel habit -3.593 -4.900 -2.285 <0.001 
Hospital Anxiety and Depression 
Scale 
Anxiety score (HADS-A) -2.342 -2.669 -2.015 <0.001 
Depression score (HADS-D) -2.444 -2.801 -2.088 <0.001 
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Table 9.4c Multivariate analysis for independent factors associated with MCS in main 
effects model 
MCS 95% C.I. for (3 
P Lower Upper p-value 
Factors 
Limit Limit 
Age 0.112 0.020 0.204 0.017 
Abnormal taste -1.255 -2.220 -0.291 0.011 
Post-prandial abdominal distension or belching -1.916 -3.043 -0.789 0.001 
Anxiety score (HADS-A) -1.077 -1.502 -0.652 <0.001 
Depression score (HADS-D) -1.392 -1.883 -0.950 <0.001 
� .. 
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10.1 CMPs Demographics and Training 
In Study 3, five hundred and twenty-nine of 4835 (10.9%) CMPs responded to the survey. 
Responders were defined as CMPs who returned the questionnaire with at least 80% of 
the queries completed. The location of the practices of CMPs who participated in the 
survey was comparable to that of the overall population of CMPs (^=0.94) (Table 10.1). 
The majority of responders were male (72.9%) and aged over 40 years (85.2%). 
Approximately eighty-four percent of responders had formal TCM education in TCM 
schools or universities while the remaining 16% of responders acquired medical 
knowledge from masters, families or self-study. Approximately 60% of responders had 
over 20 years of clinical experience. The majority of responders were practicing in 
private clinics (53.3%) or herbal store (28.2%) (Table 10.2). 
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Table 10.1 Practice location of Responders and CMPs in Hong Kong 
Location Responders* CMPs in Hong Kong P 
Hong Kong 28.0% 26.1% 
Kowloon 38.6% 41.1% 0.94 
New Territories 33.4% 32.8% 
* Responders who indicated more than one practice locations were excluded. 
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Table 10.2 Demography of CMPs (n = 529) 
Variables Valid response Percentage 
Sex (male) 402 72.9% 
Age 457 
Under 30 4.8% 
3 1 - 4 0 10.1% 
41 - 5 0 23.0% 
51 - 6 0 34.8% 
Above 60 27.4% 
Medical study path 513 
Informal Education (self-study, master and 15.9% 
apprentice /family) 
Formal Education (TCM school /university) 84.1 % 
Highest level of medical education 414 
Certificate /Diploma 39.6% 
Bachelor 46.4% 
Postgraduate (Master or above) 13.0% 
•Others 1.0% 
Clinical experience 513 
Under 5 years 5.5 % 
5 - 1 0 years 10.5% 
1 0 - 1 5 years 11.1% 
1 5 - 20 years 13.3% 
Over 20 years 59.6% 
Setting of practice 506 
Private clinic 5 3.3 % 
Herbal store 28.2% 
Home 10.1% 
Chain clinic 4.6% 
Drug company 2.6% 
**Others 1.3% 
*Other medical education referring no formal education was received 
** Other setting of practice including university clinics, hospital out-patient clinic and 
free service from charities. 
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10.2 Practice Behavior 
Three hundred and fifty out of 523 CMPs (66.9%) believed that western medical 
diagnosis of chronic hepatitis B affected their TCM diagnosis and treatment. The 
majority of the responders used to ask their patients' western medicine diagnosis during 
consultation (500 out of 527, 94.9%); practiced TCM Syndrome Differentiation (486 out 
of 508, 95.7%) and believed that TCM pathogenesis directly affected therapeutic 
approach (485 out of 524，92.6%). Four hundred and eighty-six responders (95.7%) 
were aware of the chronic hepatitis B status among their patients. Nearly all CMPs 
rated TCM as an effective treatment for chronic hepatitis B (514 out of 518, 99.2%). 
.. 
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10.3 Diagnostic and Therapeutic Approach 
Five hundred and six (96%) CMPs practiced TCM Syndrome Differentiation to 
determine treatment strategy in chronic hepatitis B. Majority of them agreed that 
chronic hepatitis B could be classified into different syndromes. Over 80% of CMPs 
agreed on the syndromes liver qi stagnation with spleen asthenia and damp-heat stasis in 
middle jiao in chronic hepatitis B (Table 10.3). On the contrary, only 62.3% of CMPs 
agreed on the syndrome asymptomatic and 54.5% of CMPs agreed on the syndrome 
spleen and kidney yang asthenia. The majority of these CMPs followed the treatment 
principle and herbal prescription that stated in "TCM differential diagnostic standard for 
viral hepatitis" and textbooks for syndromes damp-heat stasis in middle jiao, liver qi 
stagnation with spleen asthenia, liver and kidney yin asthenia, and blood stasis in 
collaterals (IMHC 1991; Wang 2002a; Wang 2002b) (Table 10.4). On the other hand, 
CMPs held diverse opinions on treatment principle and herbal prescription in 
asymptomatic syndrome. The commonest agreed treatment principle for asymptomatic 
syndrome was invigorating spleen and strengthening anti-pathogenic qi, and dispersing 
stagnant liver qi and strengthening spleen; and the most frequent prescribed formulae 
were Siaoyao San He Shen Ling Baizhu San and Chaihu Shugan San respectively. 
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Table 10.3 Diagnostic approach of CMPs who used to practise TCM Syndrome 
Differentiation to determine treatment strategy (n = 475) 
TCM syndromes of chronic Number of agreed % of agreed CMPs 
hepatitis B CMPs 
Damp-heat stasis in middle-jiao 421 88.6% 
(Dampness outweighs heat) 
Damp-heat stasis in middle-jiao 397 83.6% 
(Heat outweighs dampness) 
Liver qi stagnation with spleen 427 89.9% 
asthenia 
Blood stasis in collaterals 371 78.1% 
Liver and kidney yin asthenia 372 78.3% 
Spleen and kidney yang asthenia 259 54.5% 
Asymptomatic 296 62.3% 
77 
Chapter 10 Chinese Medicine Practitioners' Practice 
Table 10.4 Therapeutic approach of CMPs who used to practise TCM Syndrome 
Differentiation to determine treatment strategy (n = 487) 
Syndrome Treatment principle Herbal prescription 
(n, % of agreed CMPs) (n，% of agreed CMPs) 
Damp-heat stasis in Clearing away heat & promote Yinchenhao Tang or other 
middle-jiao diuresis (460，83.5%) compatible herbal formulae* 
(Dampness (372，90.0%) 
outweighs heat) 
Damp-heat stasis in Clearing away heat & promote Yinchen Wuling San or other 
middle-jiao (Heat diuresis (454, 96.3%) compatible herbal formulae* 
outweighs (381,87.1%) 
dampness) 
Liver qi stagnation Dispersing stagnant liver qi & Xiaoyao San He Shen Ling 
with spleen strengthen spleen (472, 94.0%) Baizhu San or other compatible 
asthenia herbal formulae* (366，80.6%) 
Liver and kidney Nourishing liver blood and Yiguan Jian He Liuwei Dihuang 
yin asthenia kidney yin (460，97.7%) Wang or other compatible herbal 
formulae* (387，94.1%) 
Blood stasis in Activating blood & removing Gexia Zhuyu Tang or other 
collaterals stasis (467’ 95.0%) compatible herbal formulae* 
(370’ 90.8%) 
Asymptomatic Clearing away heat & promote Yinchenhao Tang (340, 3.2%) 
diuresis (412，6.4%) Yinchen Wuling San (340’ 1.5%) 
Dispersing stagnant liver qi & Xiaoyao San He Shen Ling 
strengthening spleen (412, Baizhu San (340, 26.2% ) 
32.2%) Chaihu Shugan San (340， 
31.2%) 
Nourishing liver blood and Yiguan Jian He Liuwei Dihuang 
« kidney yin (412,5.5%) Wang (340,2.4%) 
Activating blood & removing Gexia Zhuyu Tang (340, 3.8%) 
stasis (412,8.1%) 
Invigorating spleen & Shen Ling Baizhu San (340， 
strengthening anti-pathogenic 22.1 %) 
0 ( 4 1 2 , 40.3%) 
Other treatment principles Other herbal formulae (340, 
(412，7.6%) 9.7%) 
* Other compatible herbal formulae Refer to those found in common textbooks (Wang 
2002). 
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10.4 Professional Knowledge Assessment 
On the assessment of professional knowledge of TCM Syndrome Differentiation, the 
mean score of the question on blood stasis in collaterals was of the highest (81.7 士 22.4) 
and that of liver and kidney yin asthenia was among the lowest (68.2 士 24.2). The 
average mean score of the 5 questions was 75.4 士 19.0. (Table 10.5). 
Twenty-three (4.3%) CMPs in the survey did not consider TCM diagnostic differentiation 
during patient consultation. Most of them selected the treatment regime based on TCM 
symptomatology (60.0%) and pharmacological principles of the TCM regimes (26.7%). 
The most frequently-used herbal prescriptions were Chaihu Shugen San (50%) and 
Yinchenhao Tang (40.0%). 
Regardless of the practice of TCM Syndrome Differentiation, the most commonly used 
herbal ingredients by local CMPs were Poria cocos (88.9%), Atractylodes macrocephala 
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Table 10.5 Knowledge assessment on CMPs who used to practice TCM Syndrome 
Differentiation on each TCM syndrome (Symptomatology of TCM syndrome based on 
"TCM differential diagnostic standard for viral hepatitis" and textbook) 
Knowledge assessment score Mean 士 S,D. 
Damp-heat stasis in middle-jiao (n=461) 77.7 士 19.2 
Liver qi stagnation with spleen asthenia (n=462) 71.2 士 21.9 
Liver and kidney yin asthenia (n=461) 68.2 士 24.2 
Blood stasis in collaterals (n二461) 81.7 士 22.4 
Spleen and kidney yang asthenia (n=461) 75.9 士 22.9 
Average Scores 75.4 士 19.0 
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Table 10.6 Common herbal ingredients used by CMPs 
Herbal ingredients Chinese names % of CMPs (n = 503) 
Poria cocos 茯苓(云苓） 88.9 
Atractylodes macrocephala 白朮 86.5 
Salvia miltiorrhiza 丹參 85.3 
Abrus cantoniensis Hance 雞骨草 75.5 
Ligustrum lucidum 女貞子 62.4 
Schisandra chinensis 五味子 58.6 
Ganoderma lucidum 靈芝 45.1 
Phyllanthus urinaria 葉下珠 30.2 
Cordyceps sinensis 冬蟲夏草 26 .2 
Other herbal ingredients*: 
Artemisia capillaries Thunb. 綿茵陳 15.9 
Bupleurum chinense DC 柴胡 15.1 
Paeonia lactiflora Pall 白芍 10.1 
*Other herbal ingredients referring to the herbs not listed in the questionnaire but were 
used commonly by over 10% of CMPs. 
‘ 
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10.5 Determinants of Diagnostic Approach 
On univariate analysis, the practice behavior that CMPs considered TCM pathogenesis 
affecting treatment plan was associated with the practice of TCM Syndrome 
Differentiation (Table 10.7). Other variables of practice behavior and demographic 
variables did not affect the practice of TCM Syndrome Differentiation. Among those 
CMPs who practice TCM Syndrome Differentiation, formal TCM education (TCM 
school or university education) was associated with higher knowledge assessment scores 
(Table 10.8). The association of formal TCM education {p 二 0.03, f,= 8.50，C.I.= 
2.92-14.01) with higher knowledge assessment scores remained statistically significant 
after adjustment of female gender, which has a borderline association with knowledge 
assessment on univariate analysis. 
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Table 10.7 Univariate analysis for factors associated with the practice of TCM 
Syndrome Differentiation 
" Case (% )* Control ( % ) * * p value 
Demography 
Female 103/376 (27.4%) 2/16(12.5%) 0.26 
Age (<51 year old) 165/424 (38.9%) 4/18 (22.2%) 0.22 
Formal medical training 396/467 (84.8%) 18/22 (81.8%) 0.76 
Postgraduate medical education 50/382 (13.1%) 3/16 (18.8%) 0.68 
Clinical experience (<20 years) 194/471 (41.2%) 5/22 (22.7%) 0.12 
Practice behavior 
CMPs considered western 323/481 (67.2%) 14/21 (66.7%) 0.96 
medical diagnosis affect TCM 
diagnosis and treatment 
CMPs used to inquire their 460/482 (95.4%) 20/22 (90.9%) 0.28 
patients' western diagnosis 
during consultation 
CMPs used to consider TCM 452/484 (93.4%) 14/20 (70.0%) 0.002 
pathogenesis directly affect 
treatment 
CMPs used to have chronic 415/449 (92.4%) 18/19 (94.7%) 1.00 
hepatitis B patients 
CMPs rated the treatment for 473/476 (99.4%) 21/21 (100.0%) 1.00 
chronic hepatitis B as effective 
*Case = CMPs who used to practice TCM syndrome diagnosis 
**Control = CMPs who did not use to practice TCM syndrome diagnosis 
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Table 10.8 Univariate analysis for factors associated with knowledge assessment score 
(mean 士 S.D.) 
Factors Score /?-value 
Gender 0.07 
Female 78.7 士 17.8 
Male 74.6 土 19.1 
Age 0.42 
<51 year old 76.9 士 18.4 
• 51 year old 75.3 土 18.9 
Medical training <0.001 
Formal medical training (TCM school 
76.8 ± 18.6 
/university) 
Informal medical training (self-study, master and 
67.7 ±20.9 
apprentice /family) 
Medical education 0.58 
Postgraduate (Master or above) 78.9 士 16.8 
Bachelor 76.4 士 19.8 
Diploma /Certificate 76.5 土 18.4 
Clinical experience 0.40 
<20 years 76.3 ± 19.3 
^ 2 0 years 74.7 土 19.0 
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11.1 Patients Characteristics & Disease Severity 
In Study 4，one hundred and twenty-three patients were screened and 112 patients were 
enrolled in the study (Fig. 11.1). None of these patients had regular alcohol intake of 
more than 200 grams per week. Seventy-six (68%) patients were male. The median 
ALT level was 53 (range 10 - 1139) IU/1 and 50 (44.6%) patients had elevated ALT levels 
( ^ 5 8 IU/1). The log HBV-DNA was 5.83 士 1.85 copies/ml and 67 (59.8%) patients had 
HBV DNA higher than 105 copies/ml. Fifty-five (48.2%) patients had positive HBeAg 
and 18 (16.1%) patients had Child's grade A liver cirrhosis (Liver cirrhosis was defined 
as ultrasonic features of liver cirrhosis plus evidence of hypersplenism (splenomegaly 
with a platelet count of lower than 100 x 109/1 or white count lower than 4 x 109/1), 
clinical ascites, varices, and /or hepatic encephalopathy (Chan, Leung et al. 2000)). 
Fifteen (13%) patients had co-morbid illnesses including hypertension (n=6), diabetes 
mellitus (n=4), heart diseases including ischemic heart disease, atrial fibrillation and 
mitral stenosis (n=3), thyroidectomy (n=2), previous hysterectomy (n=l), previous 
mastectomy for breast cancer (n=l), asthma (n=l) and osteoarthritis (n=l). 
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Total eligible patients 
n = 123 
11 patients excluded 
• 5 refused 
• 1 psychiatric 
— — ^ ― • 1 unable to read Chinese 
• 1 pregnant 
• 2 on drug (Lamivudine, 
Rehassure) 
•__1 nrpvinii<; rhnlprvgtprtrtmv 
112 eligible patients 
： l • 「 , Agreed by 3 CMPs No consensus 
Diagnosis: 71.4% («=80) Diagnosis: 28.6% (n= 32) 
Treatment Principle: 70.5% (n= 79) Treatment Principle: 29.5% (n= 33) 
Herbal prescription: 72.3% (n= 81) Herbal prescription: 27.7% («= 31) 
Figure 11.1 Patient recruitment and agreement summaries of TCM diagnosis, treatment 
principles and herbal prescription among 3 CMPs based on "The standards of TCM 
differential syndromes of viral hepatitis" 
� .. 
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11.2 Agreement of TCM Diagnosis & Treatment 
Based on the diagnostic criteria stated in "the standards of TCM differential syndromes 
of viral hepatitis", the average agreement and kappa-value among the CMPs on TCM 
diagnoses were 80.7% and 0.72; on treatment principle were 80.4% and 0.72 and on 
herbal prescription were 81.6% and 0.73，respectively (Table 11.1). 
Among the TCM diagnosis agreed by all 3 CMPs (80 out of 112 cases), the commonest 
TCM diagnoses were Asymptomatic Syndrome (n=32, 40.0%) and Syndrome of liver and 
kidney yin asthenia (n=31，38.8%) (Figure 11.1, Table 11.2a). Accordingly, the 
commonest treatment principles agreed by all 3 CMPs (79 out of 112 cases) were 
invigorating spleen and strengthening anti-pathogenic qi (n=32, 40.5%); and nourishing 
liver blood and kidney yin (n=30, 37.9%) (Table 11.2b). The most frequently prescribed 
herbal formulae (81 out of 112 cases) were Shen Ling Baizhu San (n=32, 39.5%) and 
Yiguan Jian he Liuwei Dihuang Wan (n二31，38.3%) (Table 11.2c). 
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Table 11.1 Simple percentage agreement and kappa-value by any 2 CMPs and their 
averages on TCM diagnosis, treatment principle and herbal prescription based on the 
standards of TCM differential syndromes of viral hepatitis 
CMPs Avs. B B vs. C Avs. C Average 
Diagnosis 
Percentage agreement 88.4% (n = 99) 81.3% (« = 91) 72.3% (« = 81) 80.7% 
Kappa-value 0.83 0.74 0.60 0.72 
Treatment principle 
Percentage agreement 89.3% {n = 100) 79.5% (n = 89) 72.3% (n = 8l) 80.4% 
Kappa-value 0.85 0.71 0.61 0.72 
Herbal prescription 
Percentage agreement 91.1% (« = 102) 80.4% (n = 90) 73.2% (n = 82) 81.6% 
Kappa-value 0.86 0.72 0.61 0.73 
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Table 11.2a Syndrome distribution agreed by three CMPs with "The standards of TCM 
differential syndromes of viral hepatitis" (n = 112) 
Syndromes No of patients Percentage Percentage (excluding cases 
without consensus among 3 
CMPs) 
Stagnation of I iver qi 14 12.5 17.5 
and asthenia of spleen 
Liver and kidney yin 31 27.7 38.8 
asthenia 
Blood stasis in 3 2.7 3.8 
collateral 
Asymptomatic 32 28.6 40.0 
No consensus among 32 28.6 ~ 
the 3 CMPs* 
Total 112 100 100 
*Damp-heat stasis in middle-jiao is not displayed in the table because no such case was 
agreed by all 3 CMPs. 
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Table 11.2b Treatment principle agreed by three CMPs with "The standards of TCM 
differential syndromes of viral hepatitis" (n = 112) 
Treatment principle No of pati ents Percentage Percentage (excluding cases 
without consensus among 3 
CMPs) 
Dispersing stagnant liver 13 11.6 16.5 
qi and strengthen spleen 
Nourishing liver blood 30 26.8 38.0 
and kidney yin 
Activating blood and 4 3.6 5.1 
removing stasis 
Invigorating spleen and 32 28.6 40.5 
strengthening 
anti-pathogenic qi 
No consensus among the 33 29.5 ~ 
3 CMPs* 
Total 112 100 100 
*Clearing away heat and promoting diuresis was not displayed in the table because no 
such case was agreed by all 3 CMPs. 
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Table 11.2c Herbal prescription agreed by three CMPs under Syndrome Differentiation 
(n= 112) 
Herbal prescription No of patients Percentage Percentage (excluding cases 
without consensus among 3 
CMPs) 
Siaoyao San He Shen 14 VL5 17.3 
Ling Baizhu San 
Yiguan Jian He Liuwei 31 27.7 38.3 
Dihuang Wan 
Gexia Zhuyu Tang 4 3.6 4.9 
Shen Ling Baizhu San 32 28.6 39.5 
No consensus among 31 27.7 ~ 
the 3 CMPs* 
Total 112 100 100 
*Yinchenhao Tang and Yinchen Wuling San were not displayed in the table because no 
such case was agreed by all 3 CMPs. 
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Interpretation of TCM Diagnosis 
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12.1 Patients 
In Study 5, the studied sample was the same as Study 4. The consensual TCM 
diagnostic approach used in Study 5 was different from that of Study 4: consensual TCM 
syndrome diagnosis among any 2 or more CMPs was made in 111 (99.1%) patients 
(Table 12.1). The commonest TCM syndromes were asymptomatic syndrome (n二37， 
33.3%), followed by liver and kidney yin asthenia (n=36, 32.4%) and stagnation of liver 
qi and asthenia of spleen (n=27, 24.3%). As the number of patients with consensual 
diagnoses of Damp-heat stasis in the middle-jiao was too small (n=3) and the diagnosis 
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Table 12.1 TCM diagnostic pattern by all 3 CMPs and any 2 of them (n=112) 
TCM diagnosis Number and percentage of patients n, (%) 
Agreed by 3 CMPs Agreed by any 2 CMPs 
Asymptomatic syndrome 32 (28.6%) 37 (33.0%) 
Liver and kidney yin 30 (26.8%) 36 (32.1 %) 
asthenia 
Stagnation of liver qi 13(11.6%) 27 (24.1 %) 
and asthenia of spleen 
Blood stasis in collateral 4 (3.6%) 8 (7.1%) 
Damp-heat stasis in the 0 (0%) 3 (2.7%)* 
middle-jiao 
Total consensual cases 79 (70.5%) 111 (99.1%) 
No consensus 33 (29.5%) 1 (0.9%) 
* Damp-heat stasis in the middle-jiao agreed by any 2 CMPs included Dampness 
outweighs heat (n = 2，1.8%) and Heat outweighs dampness (n = 1, 0.9%). 
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12.2 Clinical Characteristics 
Among the 108 consensual cases, approximately two-third of patients were male with a 
mean age of 40 years (Table 12.2). Seventeen (15.7%) patients had liver cirrhosis and 
all belonged to Child's grade A. Fourteen (12.9%) patients had comorbid illnesses 
including hypertension (n=5), diabetes mellitus (n=3), heart diseases including ischemic 
heart disease and mitral stenosis (n=2), thyroidectomy (n=2)，previous hysterectomy 
(n=l), previous mastectomy for breast cancer (n=l), asthma (n=l) and osteoarthritis 
(n=l). There was a tendency of less male predominance (52.8%) and more 
co-morbidity illnesses (25.0%) among patients with liver and kidney yin asthenia as 
compared to patients with other TCM syndromes. Patients who had asymptomatic 
syndrome and stagnation of liver qi and asthenia of spleen tend to be younger while 
those who had blood stasis in collateral tend to be older. Patients with asymptomatic 
syndrome tend to have lower ALT levels and higher HBV DNA levels. Patients who 
had syndrome blood stasis in collateral tend to have lower HBV DNA, less HBeAg 
positive rate, worse coagulopathy and more liver cirrhosis. 
.. 
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Table 12.2 Clinical characteristics of patients in relation to the consensual TCM 
syndromes 
Variables Asympto Liver & Stagnation Blood stasis Overall 
-matic kidney yin of liver qi in collateral 
syndrome asthenia & asthenia 
of spleen 
n=37 N = 36 n = 27 n=8 n = 1 0 8 
Male gender 75.7% 52.8% 74.1% 75% 67.6% 
Age 37.6+10.0 43.1+12.6 37.8±9.8 46.1±11.0 40.1±11.2 
Co-morbidities 5.4% 25.0% 7.4% 12.5% 13.0% 
ALT (median, 47 55 56 53 53 
range) / IU/1 (10-295) (17-1139) (12-471) (27-107) (10-1139) 
Log, 0 (HBV 5A+2A 5.1±2.5 5.2+2.8 4.0+2.8 5.2±2.6 
DNA) 
HBeAg 56.8% 41.7% 55.6% 25.0% 49.1% 
positive 
, P T (median, 10.4 10.1 10.2 11.2 10.4 
range) / sec (9.5-11.7) (9.3-13.5)3 (9.2-12.9) (10.1-14.7)3 (9.2-14.7) 
Liver cirrhosis 1 (2.7%) b 5 (13.9%) c 5 (18.5%) d 6 (75.0%) b" d 17 (15.7%) 
** The number of patients classified as Damp-heat stasis in the middle-jiao agreed by 
any 2 CMPs, included Dampness outweighs heat (n = 2, 1.8%) and Heat outweighs 
dampness (n = 1，0.9%), was too small and, hence, was not included for comparison. 
;ALT = alanine aminotransferase; PT = prothrombin time 
a p = 0.006; b p = 0.006; c p < 0.001; d p = 0.001 
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12.3 HRQoL Assessment 
Patients who had asymptomatic syndrome tend to have the highest scores in all aspects of 
HRQoL, and the scores of all domains were above population mean of 50 (Table 12.3). 
On the other hand, the majority of the scores of the 8 domains of the remaining 3 TCM 
syndromes were below population mean. The bigger contrast was between patients 
with asymptomatic syndrome and patients with liver and kidney yin asthenia where the 
former group had better HRQoL in all domains except the physical functioning domain. 
Patients who had asymptomatic syndrome also had significantly better HRQoL in 
domains general health, vitality and mental health as compared to those who had 
stagnation of liver qi and asthenia of spleen, and better HRQoL in the vitality domain as 
compared to patients who had blood stasis in collateral. In the perspective of summary 
scores, patients with asymptomatic syndromes had higher PCS and MCS versus patients 
with liver and kidney yin asthenia and higher MCS than patients with stagnation of liver 
qi and asthenia of spleen. 
ft 
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Table 12.3 Health-related quality of life assessment measured by SF-36 on of the 
subjects versus TCM syndromes agreed by any 2 of 3 CMPs (n = 111) 
Variables Asymptomati Liver & Stagnation Blood Overall 
c syndrome kidney yin of liver qi & stasis in 
asthenia asthenia of collateral 
spleen 
n=37 n = 36 n = 27 n = 8 n = 108 
8 domains (norm-based 50,10) 
Physical 50.8±8.3 45.3土 12.3 48.0士 16.6 42.8士 17.5 47.7±12.9 
Functioning 
Role 53.1 士8.1 a 45.6士 12.3 a 50.6士 10.0 45.6±14.8 49.4士 11.0 
Physical 
Bodily Pain 52.2士9.0 b 41.2士 10.1 b 47.9士9.3 45.4士 12.1 47.0士 10.6 
General 58.2士7.4e，d 45.8士 10.3 d 45.1 士9.7 c 44.9土 13.5 49.8士 11.2 
Health 
Vitality 54.1 士7.7e，f’g 45.5士 12.7 e 48.7士6.3 f 44.5士 11.0 g 49.2士10.2 
Social 50.2士8.4h 40.2士 12.5 h 45.3士 11.8 43.1士 18.5 45.1 士 12.2 
Functioning 
Role 54.1 士 7.2 j 46.5 士 11.11 50.6±8.1 48.7±12.3 50.3±9.7 
Emotional 
Mental 52.5±6.5 j ' k 42.8土 12.1 j 46.6±7.3 k 47.1±9.8 47.4士9.9 
Health 
2 Summary Measures 
PCS 52.9±7.0' 44.8 士 10.61 48.1 土 11.1 43.4 士 15.1 48.3 土 10.5 
M C S 53.1 士7.0m，n 43.9土 11.7 n 47.7士7.3 m 47.6士10.4 48.3土9.8 
PCS = physical component summary, MCS = mental component summary 
a p < 0.001; b p < 0.001; cp < 0.001; d p < 0.001; V = 0.003; { p = 0.003; s p = 0.005; hp < 
0.001; > = 0 .001 ; j p < 0.001; k p = 0.002; ]p < 0.001; m p = 0.004; > < 0.001 
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13.1 TCM Popularity and its Practice 
The health-seeking behavior of Hong Kong people is heavily influenced by both Western 
and Chinese culture. Using TCM to promote health is a deep-rooted practice in Hong 
Kong. In the patient survey of TCM use (Study 1)，one third of patients with chronic 
hepatitis B have used TCM. This figure is similar to that of previous surveys in patients 
with other chronic illnesses (Eisenberg et al., 1993; Eisenberg et al,’ 1998; Langmead 
and Rampton 2001). The users of TCM believed that it had moderate to good 
therapeutic benefit but little or no side effects. This might explain why a quarter of the 
patients who used TCM never consulted herbalists or CMPs before taking those agents in 
this survey. The evidence of efficacy of Chinese medicinal herbs in the treatment of 
chronic hepatitis B, however, is weak (Liu et al., 2001; Chan et al., 2003). Nonetheless, 
these patients were willing to spend substantial sums on such preparations. The 
expense was not low as compared to that of Western medicine (monthly cost of 
lamivudine is approximately US$100). 
Perception of having active hepatitis, having relatives or friends with chronic hepatitis B 
and recent travel to Mainland China are independently associated with the use of TCM 
by patients as demonstrated in Study 1. These factors in turn may reflect the health 
seeking behavior of patients in Hong Kong. Because TCM was perceived by the 
patients with moderate to good therapeutic benefit but little or no side effects, patients 
who believed of having active hepatitis may be more active to seek treatment. TCM, 
therefore, could be one of their choices. Patients who have family members or friends 
with chronic hepatitis B may take their advice to seek TCM. However, knowing family 
members or friends with hepatocellular carcinoma does not increase the use of TCM, 
suggesting that patients tend to view TCM as health enhancers instead of preventive 
treatment against liver-related complications. Patients who had recent traveled to China 
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may represent those who seek TCM treatment in China because it would be cheaper. 
Based on the patients survey (Study 1)，the most commonly used herbal ingredients, 
Abrus cantoniensis, Ganoderma lucidum and Atracty lodes macrocephala, are not 
specifically anti-viral agents. These are herbs that have been used as to improve the 
immune function and maintain normal physiological activities of the Internal Organs. 
So far, there is no clinical trial addressing the efficacy and safety of these herbal 
ingredients in the treatment of chronic hepatitis B (Liu et al., 2001). However, several 
preliminary animal experiments demonstrated possible hepatoprotective effects. A 
Japanese study suggested that Kaikasaponin III and Soyasaponin I，triterpenoidal 
saponins isolated from Abrus cantoniensis, may have anti-hepatotoxic activity in rats 
concomitantly exposed to CCU (Miyao et al., 1998). Studies in China and Korea also 
showed the hepatoprotective role of Ganoderma lucidum extracts against Mycobacterium 
bovis bacillus Calmette-Guerin-induced immune liver injury in mice and CCU-induced 
liver injury in rats respectively (Kim et al., 1999; Zhang et al., 2002). 
The practice of TCM Syndrome Differentiation among CMPs is very common in Hong 
Kong. In the survey of local CMPs (Study 3)，over 95% of local CMPs practiced TCM 
differential diagnosis to determine their therapeutic strategy when treating chronic 
hepatitis B patients regardless of CMP's education background, clinical experience and 
practice behavior. However, the recognition of the different viral hepatitis syndromes as 
described in the literature by different CMPs was variable, ranging from 89.9% in liver qi 
stagnation with spleen asthenia to 54.4% in spleen and kidney yang asthenia. Most 
CMPs followed the Syndrome Differentiation of viral hepatitis to guide their treatment 
strategies, but there was little agreement on the treatment principle and herbal regimen 
for asymptomatic syndrome. Among CMPs who practiced TCM differential diagnosis, 
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those who had formal education on TCM training had significantly better scores on 
knowledge assessment. 
The diagnostic approach of TCM is intimately related to Syndrome Differentiation, 
which is based on ancient philosophies, symptom-based clinical practice and a complex 
individualized diagnostic system. The diagnosis of TCM syndromes put strong 
emphasis on the fundamental principle that signs and symptoms reflect the imbalance 
condition of the Internal Organs or the body state. Chronic hepatitis B patients, for 
example, can be classified into different TCM syndromes according to their clinical 
manifestations (Kaptchuk 2000; Wang 2002). TCM aims to correct the TCM 
syndromes and restore the balance of the body, but not to antagonize specific 
pathogenetic targets (Jiang 2005). Each TCM syndrome has its own specific treatment 
strategy and coherent herbal prescriptions in order to restore the balance of the body 
(Yuan and Lin 2000; Wang 2002a). For example, the most agreeable syndrome in Study 
3，Liver qi stagnation with spleen asthenia, is generally treated by dispersing stagnant 
liver qi & strengthening spleen. CMPs will then formulate a rational and coherent 
treatment plan. Xiaoyao San He Shen Ling Baizhu San or other compatible herbal 
formulae are the preferred medications. 
According to the survey in Study 3, the majority of CMPs practiced TCM Syndrome 
Differentiation to determine treatment strategy in chronic hepatitis B. However, the 
agreement on TCM syndromes among CMPs was diverse. Five out of 7 TCM 
syndromes were agreed by over 78% of the total responders. Fewer CMPs agreed on 
syndrome asymptomatic (62.3%) and spleen and kidney yang asthenia (54.5%). As 
chronic hepatitis B is a relatively asymptomatic disease in early stage, the TCM 
syndrome asymptomatic was developed in modern literatures (Cui and Xu 2002; Schiff e/ 
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al., 2002). Since the classic teaching of TCM Syndrome Differentiation was primarily 
based on clinical presentation, CMPs may not be familiar with the diagnostic and 
therapeutic approach of this syndrome. CMPs' diverse opinions on the treatment 
principle and herbal prescription in syndrome asymptomatic also reflected this 
phenomenon. Spleen and kidney yang asthenia is a syndrome characterized by 
intolerance of cold and preference for warmth, cold limbs, cold pain in the lower 
abdomen, loins and knees, dull pain in the hypochondrium, lassitude, poor appetite, loose 
stools with undigested food, pale and swollen tongue, deep and slow pulse. Its clinical 
presentation is determined not only by the development of the disease itself, but also by 
factors including geographical location, heritance and composition (Wang and Lin 1997). 
Spleen and kidney yang asthenia is more prevalent in the Northern China rather than 
Southern China including Hong Kong. CMPs might consider the prevalence of 
syndrome distribution and did not include spleen and kidney yang asthenia as their 
choice. 
CMPs who practice TCM Syndrome Differentiation in chronic hepatitis B tend to use 
TCM pathogenesis to direct the treatment principle. Identifying the cause of patients' 
disharmony, i.e. TCM pathogenesis, is an important part of TCM practice. It is 
important not to consider the presenting disharmony as the cause of disease. For 
instance, if a chronic hepatitis B patient has malaise, loose stools, loss of appetite and 
dispending pain in hypochondriac region, the TCM syndrome Liver stagnation and 
spleen qi should not be considered as a cause of the disease but an expression of the 
presenting disharmony. The cause of the disharmony itself lies in the patient's lifestyle, 
dietary habits, exercise habits, etc. Identifying the cause of the disharmony is 
necessary for treatment and advice so that restoration of the harmony can minimize or 
eliminate the clinical presentation (Maciocia 1989). 
105 
Chapter 13 Discussion 
CMPs who had formal TCM training had significantly higher scores on knowledge 
assessment. In Hong Kong, there was no professional requirement to practice TCM 
before year 2000. After the legislation and implementation of the Chinese medicine 
ordinance in Jan 2000, a large number of CMPs who had never received formal training 
were allowed to register and practice if they had more than 15 years of clinical practice. 
All other CMPs need to have recognized TCM degrees and pass the licensing 
examination before they can practice in Hong Kong. The responding rate for the 
question inquiring the highest medical education (78.9%, 414 out of 529) was low 
compared with other demographic questions, probably reflecting the unwillingness of the 
CMPs to disclose their lack of formal medical training. About 16% of the responders 
did not have university training in TCM. Our results echoed the importance of formal 
education and stringent licensing for CMP practitioners. 
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13.2 Impact of TCM Symptomatology & Anxiety /Depression on 
HRQoL 
In the study of HRQoL among patients with chronic hepatitis B (Study 2), both the 
physical and mental aspects of HRQoL in patients with chronic hepatitis B were lower 
than that of the general population and were comparable to that of patients with other 
chronic diseases in Hong Kong (Table 13.1) (Lam et al,，2005). Reduced physical 
HRQoL was associated with the presence of comorbidities, complication to cirrhosis 
/hepatocellular carcinoma, TCM symptoms including discomfort over the lateral part of 
chest wall and soreness of back and /or knee, and features of depression. Lower mental 
HRQoL was associated with younger age, TCM symptoms including abnormal taste, 
post-prandial abdominal distension or belching, as well as features of anxiety and 
depression. 
TCM is intimately related to Syndrome Differentiation, which is based on the 
fundamental principle that signs and symptoms reflect the condition of the Internal 
Organs {Zhang fu). Signs and symptoms in TCM (collaborately termed TCM 
symptomatology) are used to assess bodily functions such as taste, thirst, defecation, 
‘ sleep pattern in order to create an overall picture of the disharmony inside patients. In 
Study 2，four of 14 TCM theory-based symptoms were significantly associated with 
reduced HRQoL. This implies that certain TCM symptoms including discomfort over 
the lateral part of chest wall, post-prandial abdominal distension or belching, abnormal 
taste and soreness of back and/or knee may have a negative impact on patients' 
well-beings. Discomfort over the lateral part of chest wall is regarded as a common 
TCM symptom among chronic hepatitis B patients. It includes a variety of discomfort 
associated with different TCM syndromes: hypochondriac distending pain is a classical 
manifestation of stagnation of liver qi; needle-pricked sensation in hypochondria is the 
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primary symptom of blood stasis in collateral; and dull pain in the hypochondria which 
is aggregated by exertion is common in liver and kidney yin asthenia (IMHC 1991). 
The presence of the gastrointestinal symptoms including post-prandial abdominal 
distension or belching, and abnormal taste that chronic hepatitis B often upsets the 
Liver-gall bladder and Spleen-stomach system and the resulting disharmony may 
influence the digestive process (Maciocia 1989). However, these gastrointestinal TCM 
symptoms, similar to discomfort over the lateral part of chest wall, are mixtures of TCM 
symptomatology from a variety of TCM syndromes related to many Zhang fu. For 
example, abnormal taste can have several interpretations: bitterness indicates Full-Heat 
pattern, either related to Liver or Heart; sweet taste indicates either Spleen deficiency or 
Damp-Heat; and sourness indicates disharmony of Liver and Stomach (Maciocia 1989). 
As several symptoms have a variety of interpretations, patients have identical symptoms 
may come from various TCM patterns related to different Zhang fu. 
Anxiety is a determinant of mental aspect of HRQoL among chronic hepatitis B patients, 
whereas depression is a determinant of both physical and mental aspects of their HRQoL. 
The mental burden of chronic liver disease, the need of long-term follow-up, possibility 
of complications of liver cirrhosis and hepatocellular carcinoma as well as the 
unsatisfactory current treatment options may explain the reduced mental HRQoL. The 
poorer PCS associated with depression is a common phenomenon of body-mind 
interaction. The high proportion of patients consulting CMPs and taking health 
products for this condition, as reflected in Study 1，is a good indicator of this 
phenomenon (Wong et al.’ 2005). 
The relationship of HRQoL and age in chronic hepatitis B is in accordance with the 
common phenomenon. Older age is associated with better mental HRQoL, which is 
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also observed in a local study among the general population. Younger aged subjects are 
physically fitter but have more psychological stress. Strong emulation, long working 
hours and high unemployment rate may contribute to the reduced mental aspects of 
HRQoL among younger patients (Lam et al., 1999). 
« .. 
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Table 13.1 Summary component scores of SF-36 with chronic hepatitis B patients, 
normal controls and subjects with or without chronic disease in Hong Kong population 
Number of 
patients PCS MCS 
Chronic hepatitis B patients 226 45.37 ± 10.41 47.25 ± 11.32 
Normal population* 2410 50 士 10 50 士 10 
No chronic disease* 1493 53.48 士 6.69 50.52 士 9.19 
Any chronic disease* 917 44.34± 11.76 49.15± 11.15 
* Data adopted from Lam CL, et al. (Lam et al, 2005) 
从 .. 
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13.3 TCM Diagnosis Consistency 
Study 4 assessed the consistency of TCM diagnosis and treatment strategy by different 
CMPs in chronic hepatitis B based on standardized diagnostic criteria designed by an 
expert panel (IMHC 1991). Agreements on TCM diagnosis, treatment principle and 
herbal prescription were obtained in approximately 80% of cases. One possible reason 
for the good agreement is the clear definition of primary and secondary symptoms for 
each TCM syndrome under the TCM diagnostic standard, which was designed by an 
expert panel after careful and detailed discussion. Another possible explanation is that 
the 3 CMPs received medical training in TCM universities where the traditional 
diagnostic technique "Four Diagnostic method", treatment principle and prescription 
were emphasized. This training is quite standardized in different TCM universities and 
agreement can be reached despite different backgrounds and clinical experiences of the 3 
investigators. However, our results cannot be directly compared to other studies on 
different disease entities because different diseases have different criteria to define 
syndromes. 
In Study 4，the most prevalent syndromes for Syndrome Differentiation were 
Asymptomatic (40%) and Liver and kidney yin asthenia (38.8%). The body states of 
Liver and Kidney yin asthenia as well as Asymptomatic syndrome are characterized by 
weakness of vital substances, yin and qi respectively. As chronic diseases usually result 
in impairment of healthy qi under the TCM theory, it is not surprising that the majority of 
chronic hepatitis B patients are classified into these two syndromes (Wang and Lin 1997; 
Wang 2002a). 
Apart from the high level of diagnostic consistency, good agreements on the treatment 
principles (80.4%) and herbal prescription (81.6%) were observed. The most frequent 
111 
Chapter 13 Discussion 
herbal formulae prescribed were Yiguan Jian he Liuwei Dihuang Wan (38.3%) and Shen 
Ling Baizhu San (39.5%). The former formula is prescribed for Liver and Kidney yin 
asthenia to nourish liver blood and kidney yin and the latter for Asymptomatic syndrome 
to invigorate spleen and strengthening anti-pathogenic qi. 
In real-life practice, a TCM diagnosis very often consists of features of more than one 
TCM syndrome though one syndrome may be dominant over another (Maciocia 1989). 
Among the unmatched diagnoses by the 3 CMPs in our study, the most frequent 
syndromes identified simultaneously were Liver qi stagnation with Spleen qi asthenia as 
well as Liver and kidney yin asthenia (11 out of 32). In Study 4，these 11 unmatched 
cases often were patients who had co-existing symptoms of Liver qi stagnation with 
Spleen qi asthenia as well as Liver and kidney yin asthenia. The CMPs had to decide 
on the predominant syndrome but no guideline is available according to the TCM 
syndrome differential standard. Another frequently unmatched diagnosis was 
Damp-heat stasis in middle-jiao (5 out of 32). The pattern of this diagnosis was never 
simultaneously agreed by all 3 CMPs. This is probably related to the overlapping 
clinical features of Damp-heat stasis in middle-jiao with that of other syndromes. For 
example, poor appetite, malaise, abdominal distention and loose stool are present in both 
Dampness outweighs heat and Liver qi stagnation with Spleen qi asthenia. 
The proportions of patient diagnosed who have Asymptomatic syndrome (40.0%) as well 
as Liver qi stagnation with Spleen qi asthenia (17.5%) in our study were comparable to 
that reported in Shenzhen (38.5% and 20.7% respectively) (Fan, Wu et al. 2002). 
However, Damp-heat stasis in middle-jiao, which is traditionally believed to be one of 
the major syndromes in viral hepatitis, is rarely found in our patients. Two studies in 
Southern China suggested that 17.0% to 37.9% of patients were suffering from the 
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syndrome Damp-heat stasis in middle-jiao (Fan et al.’ 2002; Yang et al., 2005). In 
Study 4，only 5 of 112 patients have suspicious damp-heat stasis in the middle-jiao as 
agreed by 1 to 2 CMPs. The primary symptoms of Damp-heat stasis in middle-jiao are 
icterus and yellowish greasy tongue coating; and the secondary symptoms are anorexia, 
nausea, fatty food phobia, hypochondriac and epigastric distention and dark yellow urine. 
In other words, these are patients with severe reactivation of chronic hepatitis B 
complicated by jaundice, and they are usually treated as inpatients in the hospital rather 
than found in outpatient clinics (Chan et al., 2002). The prevalence of severe 
reactivation of chronic hepatitis B is approximately 2% in the Chinese population as 
reported in the literature, and its low prevalence is compatible with the rare occurrence of 
syndrome Damp-heat stasis in middle-jiao in Study 4 (Sheen et al., 1985). Another 
possible explanation of the prevalence difference is the variability of environmental and 
genetic factors. In addition to symptomatology, climate, in-born constitution, life-style 
and eating habit are essential determinants of TCM syndromes (Wang and Lin 1997). 
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13.4 Association of TCM Syndromes with Western Medicine 
While the scientific basis of most TCM philosophies and methodologies is not strong, the 
popularity of TCM is increasing all over the world. Study 5 interpreted TCM syndrome 
diagnosis of chronic hepatitis B in modern medicine terminologies. Different TCM 
syndromes tend to have differences in both the clinical presentation and HRQoL. In 
particular, the syndrome blood stasis in collateral was associated with worse 
coagulopathy and more liver cirrhosis and asymptomatic syndrome was associated with 
best physical and mental aspects of HRQoL. 
Asymptomatic syndrome refers to the presence of two or less TCM symptoms; and failure 
to classify into any of the defined TCM syndromes (Qui and Qu 2002). Patients with 
asymptomatic syndrome tend to have younger age, lower ALT levels, higher HBeAg 
positivity and higher HBV DNA levels. These features are in accordance with the 
immune tolerance phase or early immune clearance phase of chronic hepatitis B in 
modern medicine as characterized by a high level of viral replication but minimal liver 
inflammation (Chan 2002; Schiff et al, 2002). As these patients are younger and 
asymptomatic, they tend to have the best HRQoL. On the other hand, patients with 
stagnation of liver qi and asthenia of spleen are similarly young with high rate of HBeAg 
positivity and higher HBV DNA levels. These patients have higher ALT levels that 
might reflect immune clearance. Under TCM theory, patients with this morbid 
condition have hypofunction of the spleen and stomach caused by the stagnation of 
liver-energy, manifested as hypochondriac distending pain, abdominal distension, loose 
stool, lassitude and emotional depression, irritability and susceptibility to rage (IMHC 
1991; Wang 2002b). Patients who have the above presentation are generally regarded 
as having less severe viral hepatitis and, hence, in the relatively early stage (Qui and Qu 
2002). 
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The syndrome liver and kidney yin asthenia tend to have less male predominance as 
compared to other syndromes. One possible explanation is the presence of some of the 
features of this syndrome among postmenopausal women, including bodily heat, dryness, 
weakness in loin and legs, dizziness, red tongue, weak and thin pulse. A study on 23 
postmenopausal women suggested that the TCM diagnosis of kidney yin asthenia was 
identified in 168 out of 207 visits by 9 CMPs (Zell et al., 2000). Patients with this 
syndrome also have lower rates of liver cirrhosis but higher rate of co-morbidity. An 
American study on 220 chronic hepatitis C patients suggested that co-morbid illness was 
the most important determinant of HRQoL (Hussain et al., 2001). This may partly 
explain why patients with liver and kidney yin asthenia tend to have the poorest HRQoL 
both in mental and physical aspects. 
The syndrome blood stasis in collateral is characterized by more severe liver disease: 
worse coagulopathy and more liver cirrhosis. Under the TCM theory, these patients 
often presented as hepatomegaly or splenomegaly with stiffness in nature, palmer 
erythema and spider naevi, which are signs of chronic liver disease in modern medicine. 
In addition to the common signs, other specific signs of blood stasis in collateral include 
cyanotic tongue and /or petechiae and congested sublingual vein. Previous studies in 
mainland China suggested that these tongue and vessel signs are the evidence of worse 
coagulopathy and thrombocytopenia (Chen and Yang 2003). Although liver cirrhosis is 
usually associated with worse HRQoL in Western series, patients with blood stasis in 
collateral in our study have similarly worse HRQoL as those with liver & kidney yin 
asthenia and stagnation of liver qi & asthenia of spleen (Marchesini et al., 2001; Hauser 
et al., 2004). This might be related to the early stage of liver cirrhosis in our cohort. 
The small number of patients with blood stasis in collateral in Study 5 may also impose 
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bias in the result and future larger-scaled studies are needed to confirm our findings. 
In Study 5，the 4 TCM syndromes characterize differently with the severity and HRQoL 
of chronic hepatitis B. We therefore propose that chronic hepatitis B in Asian patients 
may start from TCM syndrome asymptomatic; progress to stagnation of liver qi and 
asthenia of spleen, liver and kidney yin asthenia', and then develop blood stasis in 
collateral. According to TCM theory, this hypothetical syndrome progression may be 
initiated by the external pathogenic factor, damp-heat (Wang 2002b). In early stage, 
patients may have minimal symptomatology and present as asymptomatic syndrome (Qui 
and Qu 2002). Damp-heat interferes with the smooth flow of liver qi and leads to 
spleen asthenia and patients may develop stagnation of liver qi and asthenia of spleen. 
When the disease advances and affects the kidney-zang organ, patients may have liver 
and kidney yin asthenia. If the stagnation of liver qi impaired the movement of blood in 
vessels and tissues, the TCM syndrome blood stasis in collaterals results (Wang 2002a). 
When the disease progresses or relieves with an alternation of symptoms and signs, TCM 
syndromes may change accordingly. 
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13.5 Limitations of the Study 
There were several common limitations among the five studies. First, all patients in 
Study 1, 2，4 and 5 were recruited from a single hospital based clinic; the characteristics 
of patients may not accurately reflect those of patients in other parts of Hong Kong. 
Most patients attending the clinic belong to the lower or middle social classes as 
evidenced by their lower education level, nature of occupation and the relatively low 
income. In Study 1, the behavior of these patients cannot be extrapolated to the more 
wealthy patient population in the private health sector. This bias is partially 
compensated by the good reputation of the university hospital as well as the wide 
diversity of patient referrals received by the clinic. In the clinic, approximately half of 
the referrals are asymptomatic patients from community-based screening programs and 
another half are patients with symptoms or abnormal liver enzymes from family doctors 
(Chan, Hui et al. 2000). In other words, some of them may suffer from more severe 
liver disease than those patients in the primary sector. Further studies are needed before 
we can apply the results of Study 2, 4 and 5 to the general population. Second, because 
of the anonymous nature of the questionnaires in Study 1, 2 and 3，we cannot assess the 
relationship between the use of TCM and the clinical disease severity in Study 1 and 2; 
and the difference of CMPs responders and non-responders in Study 3. However, an 
anonymous questionnaire is less likely to introduce bias. For example, some patients in 
Study 1 may not want to disclose the use of TCM to their physicians. In fact, half of the 
responders who used TCM did not inform their physicians about this matter. 
Different studies also have specific limitations. In the patient survey for TCM use 
(Study 1)，patients attending hospital clinic follow-up represent those who are more 
health conscious and have more confidence in Western medicine. It is possible that the 
use of TCM is more popular in the general public. In the HRQoL study (Study 2)，only 
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generic instrument was used in our study to measure HRQoL. Validated 
disease-specific instruments, including the Liver Disease Quality of Life instrument 
(LDQOL 1.0) and Chronic Liver Disease Questionnaire (CLDQ) were developed in the 
West where very few chronic hepatitis B patients were involved (Bayliss et al., 1998; 
Younossi et al., 1999; Gralnek et al., 2000). Up to date, no validated Chinese version of 
disease-specific instrument is available for chronic hepatitis B. Efforts in translation 
and validation of these questionnaires in the Chinese population will be necessary to 
adjust for the cultural difference. In the CMP survey (Study 3)，our sample only 
represented 10.9% of the total population. Although the practice location of our cohort 
is similar to that of the overall population, we cannot access other demographic 
information for comparison. The evaluation of professional knowledge has not been 
formally validated. We tried to adopt a simple weighting system according to the 
significance of TCM symptoms based on textbooks and diagnostic criteria (primary 
symptoms are weighted double as compared to secondary symptoms). On the other 
hand, TCM practitioners, instead of 25 local TCM university students, could have been 
used in a pilot study to select the questions for use in the questionnaire. In the study on 
the agreement of different TCM practitioners on TCM syndromes (Study 4)，we set the 
choices of TCM syndrome, treatment principle and herbal prescription according to the 
criteria designed by a Chinese expert panel. But TCM theory is complex and involves a 
variety of diagnostic and treatment strategies. The combined patterns of TCM 
syndromes cannot be assessed and further studies are needed to address this issue. As 
we have excluded patients who are actively on antiviral treatments, whether anti-viral 
treatment affects the clinical feature-based diagnosis of TCM syndromes requires further 
investigation. Meanwhile, only 3 CMPs, who had very variable clinical experience, 
participated in the study. A much larger number of practitioners with similar clinical 
experience should have been used. In the study on the association of TCM syndromes 
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and Western medicine (Study 5), the number of patients with different TCM syndromes 
was not evenly distributed. Only 8 patients were classified as blood stasis in collateral 
and the syndrome damp-heat stasis in middle-jiao was rarely diagnosed. Nonetheless, 
the distribution of different TCM syndromes reflects the true phenomenon in a regional 
hospital in Hong Kong. In future, larger-scaled case-control studies among patients 
diagnosed with different TCM syndromes are required for detailed characterization. 
Owing to the small sample size and lack of statistical power, we have not adjusted the 
potential confounding variables. For example, patients with liver and kidney yin 
asthenia were the only non-male-dominant group and had poorer HRQoL. The possible 
impact of gender on HRQoL cannot be excluded. Our work can only serve as a pilot 







In conclusion, the use of TCM is very popular among chronic hepatitis B patients in 
Hong Kong. The TCM symptomatology and anxiety /depression, albeit mild, of 
chronic hepatitis B have significant adverse impacts on HRQoL of Hong Kong Chinese. 
These clinical features are usually overlooked in the practice of Western medicine. In 
terms of TCM practice, TCM syndrome diagnosis is commonly used among local CMPs. 
With good education and quality assurance, good agreements in diagnosis, treatment 
principle and herbal prescription based on TCM syndrome diagnosis among different 
CMPs in chronic hepatitis B can be obtained. Although the basic mechanism of TCM 
syndromes cannot be proved scientifically, there is modest correlation in the Syndrome 
Differentiation of TCM, clinical disease severity and the HRQoL of patients with chronic 
hepatitis B. The results of the present study have shed some light on the modern 
interpretation of the traditional wisdom of medicine in China. This information will be 
important to guide future research in the understanding of the philosophies and 
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Appendix I 【慢性乙型肝炎的治療方法問卷調查】 
......1:年齡....： :._._._. 
2. 極别： • 勇 •安 
1 3 . 學歷： •小學 口初中（中一至中三） 
•高中（中四至中七） 口大專/大學或以上 
口其他，請註明： 
| ' " "4 .福,： 
I 5 . 每 月 • 人 政 • $5,000 OT • $5,000 - $9,999 
• $10,000 - $ 19,999 • $20,000 - $39,999 
• $40,000 - $ 79,999 • $80,000 以上 
！ 6 . 婚 姻 狀 況 ： • 單 身 • 已 婚 • 離 婚 • 喪 偶 
！…7: •屋程;i•類亟： •公共屋邨 •唐屋 •租住 •自購單位 I 
•其他，請註明： 
「8: —牟內，您 口完荃沒宥 •少於一星期 
平均有多少時間逗口 一星期至一個月 口 一個月至三個月 
留在中國大陸？ •三個月至半年 •超過半年 
丨 9 .您何時第一次發現年份是： 
患有乙型肝炎？ 
I 1 0 .您毚得目B的病情 口1 口 2 口 3 口 4 口 5 
如何？ 非常輕微輕微 普通 嚴重 非常嚴重丨 
！11.—愈認；i自己的胖炎•穩定 •反覆 •活躍 •不知道 
屬於哪一類？ 
i 12.您患有肝硬化嗎？ • 有 •沒有 •不知道 
丨13.您曾經患有肝癌 • 宥 •沒有 •不知道 
嗎？ 
丨‘14. M l 乙型肝炎的 • 有 •沒有 口不知道 




！ 15."您宥恿薛癌的親葳•宥 •沒有 口不知道 






i)那麼，是甚麼 口干擾素（interferon) •拉米夫丁（lamivudine) 
類型的西 •硏究藥物 •不清楚 
藥？（可選 
| 多 ^ ^ 口其他，請註明： 
項） 
i i ) i 覺 得 成 效 口 2 口 3 口 4 D5 







(請只選擇 D覺得西藥成效不大 •擔心西藥有昌W乍用 
！ 最適合一項）•其他，請註明： 
•不知道 








| 1=1¾ S 否 • y 
• 




| 1.您爲什麼就慢性乙型肝炎•比較喜歡中藥 口擔心西藥有副作用 
而服用中藥？ 口中藥療效較好 •西醫沒有給予藥物 
(請只選擇最適合一項） 口朋友/親戚介紹 •傳媒介紹 
•其他’請註明： | 
| 2.您從哪裡得知有關中藥？ 口朋友/親戚介紹 •中醫介紹 •網上瀏覽 
| (請只選擇最適合一項） 口病友介紹 •西醫介紹 •廣告 
I — •其他，請註明： 
I 3. 您每月用於中藥之花費 口少於$100 • $100 - $499 • $500 - $999 
是： 口 $1,000 - $1,999 • $2,000 - $4,999 •多於 
$5,000 
| 4 .您覺得中藥的成效如何？ • 1 口 2 口 3 U 4 口 5 
| 毫無成效成效不大普通 有效 非常有效 
| 5 .您覺得服用中藥的副作用 口 1 口 2 口 3 口 4 口 5 
如何？ 無副作用輕微 普通 嚴重 非常嚴重 
I 6.您有沒有告訴主診西醫您曾經服用中藥？ i 
• 有 























I 2 .您爲甚麼不選擇服用中•昂貴 口沒有科學根據 | “ 
| 藥？ 口覺得沒有成效 口擔心副作用 
| (請只選擇最適合一項）口被西醫勸止 •被家人 /朋友勸止 







您曾服用的中藥類型：口沖劑 •藥九 口 口服液 •煎藥 
中成藥：（可選擇多於一項） 
•威斯蘭乙肝靈 
• 龍 江 牌 片 仔 黃 肝 寶 









• 肝 淨 
• 靈 芝 
•其他，請註明 
煎藥：您知否藥方的主要成分？ • 知 道 •不知道 
如知道，是否包括以下各項？（可選擇多於一項） 
• 珍 珠 草 
• 冬 蟲 夏 草 
• 靈 芝 
• 丹 參 
• 五 味 子 
• 女 貞 子 
143 
Appendix 
• 雞 骨 草 
• 云 苓 

























• 1.男 • 2 .女 
2.年齢 ： 歲 
3.你有沒有吸煙的習慣？ 
• 1.有 • 2.已戒了一年以下 
• 3.已戒了一年或以上 • 4.從來沒有 
4.你有沒有喝酒習慣？ 
• 1.每天都喝 • 2.已戒 
• 3.間中 • 4.從來沒有 
5.請問你的職業是甚麼？ 
(如已退休’則塡上退休前的工作） 
• 1.企業家 • 2.行政人員 • 3.專業人士 
• 4.教師 • 5.護士 • 6.紀律部隊 
• 7.社工 • 8.售貨員 • 9.工廠工人 
• 10.技工 • 11.文員 
• 12.其他（請註明： ) 




• 1.少於 $10000 • 2. $10000-30000 
• 3. $30000-$50000 • 4.多於 $50000 
7.住所類別： 
• 1.公屋 • 2.居屋 • 3.私人樓宇 
• 4•木屋 • 5.(請註明： ) 
8.婚姻狀況： 
• 1.已婚 • 2.離婚 • 3.喪偶 • 4.未婚 
9.你有沒有子女？ 
• 1.有 • 2.沒有 
10.如有子女，請問年紀最小的現年多少歲 ？ 歲 
11.請問你家中有多少人需要你供養 ？ 人 
12.敎育程度： 
• 1.小學或以下 • 2.中學 • 3.大學或以上 
13.你有宗教信仰嗎？ 
• 1.沒有 
• 2.基督教 • 3.天主教 • 4.佛教 
• 5.道教 • 6.回教 




• 1.非常認識 • 2.頗認識 • 3. 一般 
• 4.不太認識 • 5.不認識 
15.你認爲乙型肝炎會弓丨致肝硬化嗎？ 
• 1.會 • 2.不會 • 3.不知道 
16.你認爲乙型肝炎會引致肝癌嗎？ 
• 1.會 • 2.不會 • 3.不知道 
17.你知道自己患有乙型肝炎幾多年 ？ 年 
18.你有曾經患上肝硬化嗎？ 
• 1.有 • 2.沒有 
19.你有曾經患上肝癌嗎？ 




• 2.糖尿病 • 3.高血壓 • 4.心臟病 
• 5.慢性呼吸系統毛病• 6.中風 • 7.精神病 
• 8.癌症 • 9.腎病 
• 10.其他（請註明： ) 
21.你擔心會把乙型肝炎傳染給其他人嗎？ 




• 1.過於頻密 • 2.略爲頻密 • 3.適中 
• 4.略爲稀疏 • 5.過於稀疏 
23.你對抽血的頻密程度有何看法？ 
• 1.過於頻密 • 2.略爲頻密 • 3.適中 
• 4.略爲稀疏 • 5.過於稀疏 
24.在過去一年內，你曾經接受以下哪一項治療？ 
• 1.干擾素 • 2.抗病毒藥物（如拉米夫定） • 3.沒有 
25.在過去一年內，您有服用過健康食品嗎？（如維他命九、靈芝補品等） 
• 1.每天食用 • 2.間中食用 • 3.沒有食用 
26.在過去一年內，你有試過就乙型肝炎接受中藥治療嗎？ 
• 1.有 • 2.沒有 
27.在過去一年內，你有沒有因乙型肝炎引起的不適而需要留院接受治療？ 
• 1.有 • 2.沒有 
28.在過去一年內，你平均每月爲治療乙型肝炎花費了多少（包括看醫生的費用藥 
物、健康食品等)？ 
• 1.少於 $500 • 2. $500-$3000 • 3.多於 $3000 
29.你的家人當中有慢性乙型肝炎患者嗎？ 




• 1.有 • 2.沒有 • 3.不知道 
31.你的家人有患上肝癌嗎？ 
• 1.有 • 2.沒有 • 3.不知道 
32.你認爲其他人會歧視乙型肝炎帶菌者嗎？ 





相 當 大 部 
從來 常常 






1 2 3 4 5 6 7 
b.你有沒有皮膚痕癢？ 1 2 3 4 5 6 7 
c.你有沒有感到眼睛乾澀？ 1 2 3 4 5 6 7 
d.你有沒有頭暈或頭痛？ 1 2 3 4 5 6 7 
e.你有沒有腰膝痠（音：酸）軟？ 1 2 3 4 5 6 7 
f.你的手心、腳心或者胸口任何一 
1 2 3 4 5 6 7 
處有没有發熱的感覺？ 
g.你有沒有失眠？ 1 2 3 4 5 6 7 




相 當 大 部 
從來 常常 




1 2 3 4 5 6 7 
粘感其中任何一種的感覺嗎？ 
j.你有沒有感到口乾或喉嚨乾？ 1 2 3 4 5 6 7 
k.你有沒有胃部不適？ 1 2 3 4 5 6 7 
1.你進食後有沒有肚脹、肚瀉、或 
1 2 3 4 5 6 7 
吐胃氣等現象？ 
m.你有沒有食慾不振？ 1 2 3 4 5 6 7 
n.你的大便習慣有沒有不正常的 









• 1 .極好 • 2 .很好 • 3 .好 
• 4. 一般 • 5 .差 
2.和一年前相比較’你認爲你目前全面的健康狀況如何？ 
• 1.比一年前好多了 • 2.比一年前好一些 • 3.和一年前差不多 
• 4.比一年前差一些 • 5.比一年前差多了 
Copyright ©.1995 Health Assessment Lab. All rights reserved. 





活動 有很大限制 有一點限制沒有任何限制 
a.劇烈活動，如跑步、搬重物或 
1 2 3 
參加劇烈的的體育活動 
b.中等強度的活動，如搬桌子、 
使用吸塵機清潔地面、玩保齡 1 2 3 
球或打太極拳 
c.提或攜帶蔬菜、食品或雜貨 1 2 3 
d.上幾層樓梯 1 2 3 
e.上一層樓梯 1 2 3 
f.彎腰、跪下或俯身 1 2 3 
g.步行十條街以上（一公里） 1 2 3 
h.步行幾條街（幾百米） 1 2 3 
i.步行一條街（一百米） 1 2 3 
j.自己洗澡或穿衣服 1 2 3 
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a.減少了工作或其他活動的時間 1 2 
b.實際做完的比想做的要少 1 2 
c.工作或其他活動的種類受到限制 1 2 
d.進行工作或其他活動時有困難（例如覺得更爲吃力）~ 1 2 
5.在過去四個星期內，你在工作或其他日常活動中，會不會因爲情緒方面的原因 
(如感到沮喪或焦慮）而遇到下列的問題？（請圈出適當的答案） 
“ 會 不會 4 ____________ 
a.減少了工作或其他日常活動的時間 1 2 
b.實際做完的比想做的要少 1 2 
c.工作時或從事其他活動時不如往常細心 1 2 
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• 1 .毫無妨礙 • 2 .有很少妨礙 • 3 .有一些妨礙 
• 4 .有較大妨礙 • 5 .有極大妨礙 
7.在過去四個星期內，你的身體有沒有疼痛？ 
• 1 .完全沒有 • 2 . 很輕微 • 3 . 輕微 
• 4 . 有一些 • 5 . 劇烈 • 6 .非常劇烈 
8.在過去四個星期內，你身體上的疼痛對曰常工作(包括上班和家務)有多大影響？ 
• 1 .毫無影響 • 2 .有很少影響 • 3 .有一些影響 
• 4 .有較大影響 • 5 .有極大影響 ^ 
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常常 |大部分 |頗多 從來 
有時 偶爾 
如此 時間 時間 沒有 
a.你覺得充滿活力？ 1 2 3 4 5 6 
b.你覺得精神非常緊張？ 1 2 3 4 5 6 
c.你覺得情緒低落，以致於 
1 2 3 4 5 6 
沒有任何事能使你高興？ 
d.你感到心平氣和？ 1 2 3 4 5 6 
e.你感到精力充足？ 1 2 3 4 5 6 
f.你覺得心情不好，悶悶不 1 2 3 4 5 6 
‘ 樂？ 
g.你感到筋疲力盡？ 1 2 3 4 5 6 
h.你是個快樂的人？ 1 2 3 4 5 6 
i.你覺得疲倦？ 1 2 3 4 5 6 
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• 1.常常有妨礙 • 2.大部分時間有妨礙 
• 3 .有時有妨礙 • 4 .偶爾有妨礙 
• 5 .完全沒有妨礙 
11.如果用下列的句子來形容你，你認爲有多正確？(請圈出適當的答案） 
| 肯 定 | 大 致 | 不 知 大 致 肯 定 
正 確 正 確 道 不 對 不 對 
a.你好像比別人更容易生病 1 2 3 4 T " 
b.你好像所有你認識的人一 1 2 3 4 5 
樣健康 
c.你覺得自己的身體狀況會 
1 2 3 4 5 
變壞 
d.你的健康極好 1 2 3 4 r ~ 
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• 1.大部分時候感到 • 2.很多時候感到 
• 3.有時候、間中感到 • 4 .完全不感到 
2.你依然享受你以前享受的事物： 
• 1.肯定和以前一樣 • 2.有點不及以前 
• 3 .只及以前少許 • 4 .和以前差得極遠 
3.你有一種驚恐，好像有些可怕的事情會發生： 
• 1.很肯定有，而且相當厲害• 2.有，但不太厲害 
• 3.有少許，但不令我擔心 • 4 .完全沒有 
4.你能看到事物有趣的一面並且會心微笑： 
« • 1.和以前一樣 • 2.有點不如以前 
^ • 3 .肯定不如以前 • 4 .完全不能 
5.煩惱的念頭在你的腦海中浮現： 
• 1.絕大部分時候 • 2 .很多時候 
• 3.有時候，但不太常 • 4 .只是間中 
6.你感到高興： 
• 1.完全不感到 • 2.不時常感到 




• 1.肯定能夠 • 2.通常能夠 
• 3.不時常能夠 • 4.完全不能 
8.你感到缺乏衝勁，整個人都慢下來： 
• 1.差不多全部時候 • 2.非常多時候 
• 3.有時候 • 4.完全沒有 
9.你有一種忐忑不安的驚恐（十五、十六的感覺）： 
• 1.完全沒有 • 2.間中有 
• 3.相當多時候有 • 4.很常有 
10.你對自己的儀容已失去興趣： 
• 1.肯定失去 • 2.比我應該關心的少 
• 3.可能比我以前關心的少 • 4.我像以前一樣關心 
11.你感到不能安靜，像要不停地走動： 
• 1.很強烈 • 2.相當強烈 
• 3.不太強烈 • 4.完全沒有 
12.你對未來的事抱有熱切期望： 
• 1.和以前一樣 • 2.較爲不如以前 
^ • 3.肯定不如以前 • 4.絕無僅有 
13.你突然感到驚惶失措： 
• 1.非常多時候 • 2.相當多時候 
• 3.不太多時候 • 4.完全沒有 
14.你能享受喜歡的書、電台或電視節目： 
• 1.經常能夠 • 2.有時候能夠 




Appendix III �香港中文大學醫學院內科及藥物治療學系 
香港中醫師診治慢性乙型肝炎的硏究】 
慢性乙型肝炎，下列簡稱乙肝；舊稱乙型肝炎病毒攜帶者，下列簡稱帶菌者° 
| 1.您認爲西醫的診斷(病名)對中醫•有 •沒有 
j治療疾病有沒有直接的影響？ 
I_口：乙匠，包括躉稱帶菌者) j 
I 2.您診症的過程中會否詢問患者 • 會 •不會 
|己有的西醫診斷？ 
| (例如：乙肝，包括舊稱帶菌者） 
3.您認爲中醫的病因病機對中醫 • 有 •沒有 
|—迨痙麵趣麵•的鬏響?： 
| 4.您的病人中有沒有患有乙肝（包口有，每年約有多少個病人？ 
括舊稱帶菌者）？ • 1 0個以下• 10-20 口21-50個 | 
• 51-100 個 口 101-200 • 200 個以上 
•沒有注意 . 
| 5.您覺得中醫治療乙肝（包括舊稱•有效 • 無 效 
帶菌者）的療效如何？ 
I (療效包括症狀改善或化驗指 IW ： ！ I 
V I 6 .您診斷時有沒有考慮中醫的辨證分型? j 
— -
/ � 
： • 有 •沒有 
甲部，第2頁 乙部，第6頁 i M 
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甲、認爲中醫辨證分型對治療有直接影響（認爲沒有直接影響+第6頁） 
| 1.您認爲中醫的辨證分型對丨•有 •沒有 
| 中醫治療疾病有沒有直接 
’ I—的影響? | 
| 2.您認爲乙肝的證型包括：：•濕熱中阻證(濕重於熱） •瘀血阻絡證： 
(可選擇多項） | 口濕熱中阻證(熱重於濕） • 肝 腎 陰 虛 證 i 
•肝鬱脾虛證 •脾腎陽虛證 
I•邪伏脈絡(無明顯餓者) 
丨口其他’請註明： ！..; I 
搶挂 ：..,.,.,..^ 
| 3.濕熱中阻型（濕重於激）乙丨口清中焦濕熱 口活血化瘀 
肝的治法是： •疏肝扶脾/健脾 •健脾扶正 
| •養肝益腎 : — 
| | •其他，請註明: 
| 4 .濕熱中阻型（ J f f i於濕）乙口清中焦濕熱 口活血化瘀 
肝的治法是： •疏肝扶脾/健脾 •健脾扶正 
丨 • 醒 益 琶 
丨•其他’請註明： i 
^ 5 .肝變脾虛型乙肝的治法是：•清中焦濕熱 口活血化疲 
1
 •疏肝扶脾 /健脾 •健脾扶正 
、 I....•一養歴腎 | 
. ！ •其他’請註明： | 
j ~ ~ ； j 
！ 6.瘀血阻絡型乙肝的治法是：| •清中焦濕熱 •活血化瘀 
| . | •疏肝扶脾 /健脾 •健脾扶正 
r . |•養肝益腎 | 
丨 •其他，請註明: | 
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j 7.肝腎陰虛型乙肝的治法是：丨口清中焦濕熱 口活血化瘀 
| •疏肝扶脾 /健脾 •健脾扶正 
. | |•...養肝益腎 | 
、 丨•其他，請註明： | 
| 8.邪伏脈絡型（無明顯症狀者）I •清中焦濕熱 •活血化瘀 
乙肝的治法是： •疏肝扶脾 /健脾 口健脾扶正 
I •養肝益賢 ：—| ！ 
I •其他，請註明： | 
方藥：首選方劑 
{ "f r 1 
I 9 .濕熱中阻型（濕重於熱）口茵陳蒿湯 口 一貫煎合六味地黃九丨 
乙肝的首選方劑是： 口茵陳五苓散 •膈下逐瘀湯 
•逍遙散合參苓白朮散 •參苓白朮散 
I . . . . . • . . . . . . 麵 疏 肝 散 I 
！ •其他 ,請註明： 
110.濕熱中阻型（熱重於濕）•茵陳蒿湯 | •一貫煎合六味地黃九 | 
乙肝的首選方劑是： 口茵陳五苓散 口膈下逐疲湯 
I •逍遙散合參苓白朮散 口參苓白朮散 
I•柴胡疏肝散 
“ ！ •其他，請註明： | 
丨11.肝鬱脾虛型乙肝的首選方；•茵陳蒿湯 丨• 一貫煎合六味地黃九| 
w 劑是： | 口茵陳五苓散 •膈下逐瘀湯 
• | •逍遙散合參苓白朮散 口參苓白朮散 
I....荦胡疏肝散 
I •其他’請註明： I 
I I ： ； j 
丨12.瘀血阻絡型乙肝的首選方| •茵陳蒿湯 • 一貫煎合六味地黃九 
劑是 : •茵陳五苓散 •膈下逐瘀湯 
•逍遙散合參苓白朮散 •參苓白朮散 
| . . ‘ 丨.•柴胡疏肝散 
I •其他，請註明： | 
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丨13.肝腎陰虛型乙肝的首選方丨口茵陳蒿湯 丨口 一貫煎合六味地黃九| 
劑是： 口茵陳五苓散 •膈下逐瘀湯 
| •逍遙散合參苓白朮散 •參苓白朮散 
. 、 | I.. ..•柴胡疏肝散 I | 
| - | •其他，請註明： | 




•其他，請註明： ； ！ 
— 趣 , 
| 15.您認爲乙肝屬 | •身目發黃，色澤鮮明 • 口 粘 
濕熱中阻證的症狀包括：•苔黃膩 • 口苦 
(可選擇多項） | •惡心 口大便粘滯臭穢或先乾 
• 厭 油 後溏 
• 納 呆 口 口渴欲飲或飲而不多 
！ •脅脹脘悶 口肢體困重 
| • 尿 黃 •倦怠乏力 
•脈弦滑數 
»» 
、丨 丨•其他，請註明： I 
I [ 16 .您認爲乙肝屬 丨•脅肋脹痛 •胸悶太息（歎息） 
肝鬱脾虛證的症狀包括：•抑鬱煩悶 口性情急躁 
(可選擇多項） | 口腹脹 •納食減少 
_ | • 便 溏 • •淡乏味 
| •大便溏泄或食谷不 •少氣懶言 
|化，每因進食生冷油膩及口面色萎黃 
不易消化的食物而加重 口身倦乏力 
；.•舌淡有齒印 ： • 脈 沉 弦 
I . ： •其他，請註明： | 
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丨17.您認爲乙肝屬 | •頭暈 口四肢拘急 丨 
肝腎陰虛證的症狀包括：•目澀 口筋惕肉瞷 
(可選擇多項） | 口腰膝痠軟 口耳鳴如蟬 
| •舌紅少津 • 口燥咽乾 







I 18.您認爲乙肝屬 I 口面色晦暗，或見赤縷紅鬥 
•兩脅刺痛 
瘀血阻絡證的症狀包括：絲 n 
, - 、 r r i L f J r - •女子 f了經腹痛或,經色 
(可選擇多項） 口肝脾腫大，質地較硬 _ — & 
暗紅有塊 
•舌質暗或有瘀斑 
鬥 ^ ^ •脈沉細澀 
|•輕’蜘蛛痣 
•其他，請註明： 
| 19.您認爲乙肝屬 | •畏寒肢冷 •面色不華或晦黃 
脾腎陽虛證的症狀包括：•精神疲倦 •食少脘痞 
(可選擇多項） | •脈弱 口小便不利，或餘瀝不 
“ •少腹腰膝冷痛 盡’或尿頻失禁 
、 •食少便溏甚至晨泄 口舌淡胖，有齒痕 
、 i •下肢浮腫 口苔白或膩或滑 






| l .您如何選擇治療方案？丨•根據症狀 •根據西醫診斷治療用藥丨 
(請選擇最適合一項） | •根據現代藥理硏究 
| •其他’請註明： 
| 2.您治療常用的方劑包括：丨•茵陳蒿湯 丨• 一貫煎合六味地黃九 
(可選擇多項> | •茵陳五苓散 • fll下逐瘀湯 
| •逍遙散合參苓白朮 口柴胡疏肝散 
|散 口參苓白朮散 
I.口其他，請註明： 







• 方 藥 常 用 的 中 藥 包 括 ： • 珍 珠 草 •五味子 
(可選擇多項） 口冬蟲夏草 口女貞子 
• 靈 芝 口雞骨草 
• 丹 參 • 雲 苓 
• 白 朮 
•其他，請註明 
J • 針 灸 ： 
• 推 拿 ： I 
• 其 他 請 註 明 ： 
： 盤 變 
|l .年齢： • 3 0歲或以下 • 3 1 — 4 0 歲 
• 4 1 — 5 0歲 口 5 1 - 6 0歲 
• 61歲或以上 
〖2.性別: • 男 • 女 | 
I 3.學醫途徑： • 自 學 口師徒傳承 
•本地中醫學院 /大學 口內地中醫學院/大學 
•其他，請註明： 
i 4.醫學教育： • 文 憑 • 碩 士 
• 學 士 口博士 
•其他，請註明： 
5.行醫經驗： • 5年以下 • 5 — 1 0 年 
“ • 1 0 — 1 5 年 • 1 5 年 — 2 0年 
” | • 2 0年以上 
；6.行醫地點 口私人診所 •藥材舖 •連鎖診所 
• 住 宅 •醫藥公司 口醫院 
•其他，請註明： 






Appendix IV 香港中文大學內科及藥物治療學系 
中醫肝病範疇症狀問卷 
第一部分 
請根據閣下 H ^ i l的健康情況回答以下問題’只可選 1項 
....1.…！薈丽涵 
異常感覺？ 
•脹悶•針刺丨口灼熱•正常 R f f ^ S 樣痛 I 疼痛： J動後加 
2.您感到心情抑 
鬱煩悶嗎？ • 常 常 •很少 /從不 
：……....丨 .1...…..., —] 
3 .您口中有沒有 ^ I _ I ^  ^ 
異常味道？ • 口 淡 • 口 苦 | • 口 酸 • 膠 粘 感 • 無 異 常 
....4：—苡〒画涵^ ；— I . . . . ^ ! I...二..... —：鬥 
合形容你 • 口 乾 想 渴 • 口 和 喉 嚨 I •不口乾’飮•以上均不 
水，但飲水 乾，喜歡 水量正常 適用 
量不多 飲水 I 
5 .页〒 i項形容 
鬂白I食愁最 •過盛 •正常 • 差 •時好時壞 
好？ 
...6：—lipESSS 
••品嗎？ •怕 •不怕 
〜 ！ 
. . . . .7.... . . .IW^SfPS 
f u r •常常 •很少 ,從不 
..._..[豐？有皮膚—•有.........=—：：.......：..旧沒有 
—9T!進食後有沒 1 I ： 
%i%ffim) o m m •肚脹 /胃脹•食後肚瀉 
j ！ 
1 0 :恧涵蓺胄韶芣门右 I 门 为 右 ： _ ? ： •有 ；•沒有 I 
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： T j 
11以下那垣开乡容 
您的大 i 情況•， n ^ ^ ® ) I uwm 
最好？ 請答11題 丨請答11題 \請答10a’b’c及d 








稀爛？ •會 •不會 
項形容 ^ ^ ^ ^ •無規律 
您 的 大 便 次 數 • 數 5 》 • 母 天 1 次 3 天 % 有 時 — 天 ！ 次 ， 
最好？ 一 天 1 次 I 1 天 一 次 | 有 時 1 天 — 次 
13.苡〒开乡容 
•色黃 丨•正常 丨•色淡 
數情況） I ； 
i i 您 容 i 
己大部分時間 •精神好 •容易疲勞 
的精神狀態？丨 1 
15.您宥苡〒•跃 | n N , 
嗎？(可選多於•頭暈 •耳鳴 •眼花 •頭重墜 ^ 工 
1 項 ) ；白… 
1 6 . 您 感 到 _ 睛 乾 门 七 丨 门 、 々 右 
g 嗎？ •有 丨•沒有 
• . . . . . i r M m m m — — 
痠軟(腰部及膝 




^ n j g ？(可選多 、 怎匕 




1 9 . 您 获 態 门 丁 加 舶 .门由訂 




I r i f S M i ？ •宥請福續回答以〒_ • 沒 . 習 價 調 S 
i 
9 日 ^ ^ 日 飒 • 有 纖 “ 及 办 旧 沒 有 請 答 第 2 題 . . . . . „ . 
S重腹S •脹痛 •刺痛 
；二莧販°丨L 2 b您的經血是否暗紅色或咖啡色，及有血塊？ 
—痛 ^ • 晕 [•否 
3 .月經的顏色是•偏淡 | •偏深紅 •正常 
‘ i — 
“ -““•••••••• ••j 卜" -
4.月經周期是 •定期 •遲來 •早來 •時早時遲 
5.月經經期是 口2天或以下 丨口3-7天 C 1 7天以上 
' ' ' 6 . … M 1 1 1 I 1 ‘‘ 
期前後’您有•有 • 沒 有 
無感覺乳房脹 i u 月 U 仅 妇 




• 常 常 ( 每 天 ） • 有 時 + • 很 少 •從不 
片，炸子雞及 ：（數天1次） 
其他煎炸食 
— 趟 I | 
2
' SSJI •常常 (每天）•有時 I • 很 少 •從不 
(數天1次） 
“良口口 / 
" i T i 房 事 • 每 周 3 次 或 • 每 周 1 - 2 次 •每周少於1 •不適用 
數是 以上 次 
4 . 慾 , • 有 請 答 4 a ， b • 沒 有 請 答 第 5 題 
- 嗎 I I 
I 4 a您莓雨罕筠 i動幾次？（ S次須多菸 3 0 芬 i ) 
|口 1 次 口 2 次 口 3 次 C 1 4 次 口 5次或以上 
I 4 b您•面罕玛蓮®]合共多少0#間？ 
• 3 0 分鐘或以下（ 1 1 3 1 分鐘至 1 小時 E ] 2 小時 1 分 - 5 小時 
|口 .5...尘殖..1全10.趟 • l O / j N B f 
5.您多數入睡I • 零 晨 1 時 或 以 前 • 零 晨 1 時 以 後 S J S ^ P B . 
的時間是 丨請註明時間： 請註明時間： 肺社明時间• 
： I izzzzi ； 
170 
Appendix 
6: 1¾哭罕筠—— n 卜 
睡眠的時間 1116小時或以下 口6-8小時 




' •是 1 •不是 
8 . 缀 麵 • 是 •不是 
^了 m 夏丙 
——有吸煙嗎1 
10.您1個月內 • 有 • 有 









(1)精神 丨•精神良好 | •精神疲倦 
^ _ •面黃（詳見⑶） I •顴紅 •無異常 
( 2 )
 •萎黃 /咣白 I •晦暗，或見赤縷紅絲 
•不華或晦黃 •黧黑 
目黃I • 有 I • 無 
⑶發黃 ！ 
身黃丨•發黃而色澤鮮明 •發黃而色澤晦暗 •無異常 
(4)體型 •肥胖 | •正常 •消瘦 
！ — — 
• 舌 紫 暗 / 
(5)舌色 •舌淡 •舌淡紅 •舌紅 舌 青 紫 / 瘀 
斑 
^ •苔薄白 /1 • 苔 少 / 無 苔 • 其 他 ： — 
( 6 )舌台 •苔白腻 g 台頁膩 Z | •剝苔 
厚 
(7)舌體 •大小正常 •瘦 I •胖大 •邊有齒印 
：—I -—t 
(8)舌質 • 滑 •正常 I D S 
...否语〒画 
(單項或多項選•正常 •紫暗 •曲張 
、 擇） i 





2.切診 I I ] I ！ 
m、脈免 •數 •緩（正常） I •遲 
(Imw^m •滑 •弦 •溋 
： ： •細 •弱 I •沉 
进捧） ：•有力 • 無 力 
I [ ' I ！ 
l # i I •沒宥 
！ (13)腹部觸診I部位丨胃痛 r•沒有 
I 面 I I •沒宥 
1 ® — l 匪麗， . n i l ? — — I . . . . . n g I.•沒宥 
乙部 
一、_證芬型—n 1.虛證 
(單項選擇）• 2 .實證 








二、治法 Dl. i i 
(單項選擇）• 2.瀉實 
• 3.補虛瀉實 





三 、 ‘ • 1.函 _涵蕩 
(單項選擇）• 2.茵陳五苓散 
• 3.逍遙散合參苓白朮散 
： • 4.柴胡疏肝散 






0 0 4 3 5 9 0 6 2 
